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ABSTRACT OF DISSERTATION 
SURFACE FUNCTIONALIZATION VIA PHOTOINITIATED RADICAL 
POLYMERIZATION FOR RARE CELL ISOLATION AND MECHANICAL 
PROTECTION 
Surface functionalization of living cells for cell therapeutics has gained 
substantial momentum in the last two decades. From encapsulating islets of Langerhans, 
to cell laden gels for tissue scaffolds, to individual cell encapsulation in thin hydrogels, to 
surface adhesives and inert surface camouflage, modification of living cell surfaces has a 
wide array of important applications. Here we use hydrogel encapsulation of individual 
cells as a mode of protection from mechanical forces for high throughput cell printing, 
and chemical stimuli for the isolation of rare cells in blood. 
In the first study, we review methods of surface functionalization and establish a 
metric of potential target biomarkers for circulating tumor cell (CTC) isolation. For 
extended applications in cancer detection through a fluid biopsy, common surface antigen 
densities were quantitatively assessed in relation to peripheral blood mononuclear cells 
(PBMCs) for potential targets of cell specific encapsulation. We then look to 
commercialization of our process after considering biopsy volumes and cell therapy dose 
sizes. Undesired batch-to-batch variation in our in-house synthesized photo-initiator 
could be eliminated by the use of fluorescein, a commercial fluorochrome of similar 
initiating power to our current eosin initiating system. Fluorescence and hydrogel 
generation were compared indicating a fluorescein conjugate has comparable power to 
that of our in-house conjugated eosin. Parameters involving the number of cells and fluid 
volumes processed were then analyzed systematically. Key parameters were studied to 
determine optimal equipment and protocol for clinically relevant batch sizes. The final 
study looks at the mechanical protection provided by thin hydrogel encapsulation. With 
growing interests in 3D bioprinting and goals of viable whole organ printing for 
transplant, high resolution and high throughput printing is a growing need. 3D bioprinting 
presents intense mechanical stimuli in the process that cells must endure. Here we 
analyze how hydrogel encapsulation reinforces the cellular membrane allowing cells to 
withstand the damaging forces associated with bioprinting. 
KEYWORDS: cell encapsulation, bioprinting, photopolymerization, surface 
polymerization, isolation. 
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CHAPTER 1. INTRODUCTION 
1.1 Introduction 
Cell surface modifications are on the forefront in engineering in medicine because 
of the numerous applications and potential benefits they enable. The surface engineering 
of living cells is being applied in fields that range from drug delivery for specific diseases, 
to immuno-camouflage for transplantations and transfusions, to cyto-protection from 
chemical and mechanical insults. These modifications are achieved through a number of 
pathways depending on the desired goal or application. Pathways include covalent 
coupling, electrostatic interactions, antibody/antigen binding, hydrophobic insertion, 
enzymatic reactions and more. Each of these pathways possess advantages and 
disadvantages that may be better suited for a specific application over another. For 
example, hydrophobic insertion is a technique that is fast and has the ability to insert a 
large abundance of desired fluorochromes or functional groups to the cell surface. 
However, this technique lacks the specificity that may be desired when dealing with a 
heterogeneous population or when trying to isolate a specific cell phenotype. 
Specificity is especially important in applications of viable cell sorting. The two 
most common methods of isolation are magnetic activated cell sorting (MACS) and 
fluorescent activated cell sorting (FACS). Both of these methods rely on surface binding 
of phenotypic antigens to distinguish target cells from the rest of the population. MACS 
uses magnetic micro beads functionalized with antibodies to bind with target cells. The 
population is then subjected to a magnetic field in which bound target cells are retained 
while antigen negative cells pass freely through the field.  FACS is similar in its antibody 
specificity but instead uses fluorochromes. With the help of flow cytometry, cells are 
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analyzed individually for a specified fluorescence channel intensity to determine antigen 
positive events from negative events. These methods are both limited by the abundance of 
the target antibodies at the cell surface. MACS binding must be strong enough to 
immobilize target cells while allowing negative cells to pass through. FACS must bind 
sufficient fluorochromes to amplify fluorescent intensity much beyond that of 
autofluorescence and non-specific adsorption. Low availability of target surface antigens 
greatly decreases the sensitivity of these sorting techniques. While magnetic sorting has 
the ability of high cell throughput, it is accompanied with relatively poor isolation purity 
when compared to FACS and requires moderately expensive reagents (biorecognition 
magnetic beads). Isolation purity is very high for FACS, but at a cost of slow processing 
and very expensive equipment. High purity isolation with fast processing time and 
inexpensive equipment is greatly needed. 
 Our lab has developed a novel surface modification strategy in which cells are able 
to be individually encapsulated in a thin hydrogel using visible light photoinitiated free 
radical polymerization for high purity and high throughput isolation with common 
laboratory materials. Hydrogel encapsulation is achieved through the immobilization of a 
photoinitiator on the surface of living cells through antigen/antibody recognition. In the 
presence of 530 nm initiating light, local polymerization occurs near the surface of target 
cells encompassing them in a thin hydrogel while leaving non-target cells unaltered. This 
hydrogel acts as a protective barrier to chemical and mechanical stimuli allowing this 
technology to have a wide array of applications including cell isolation, or membrane 
reinforcement for high throughput cell printing. This technology has the specificity of 
antibody/antigen binding with high throughput processing making it a powerful tool in a 
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clinical setting. The system is very easily adapted to fit nearly any desired specification. 
Immobilization of the photoinitiator on the surface of the cell can be achieved by 
antigen/antibody binding, covalent coupling, or hydrophobic insertion making this a very 
versatile technique. Polymer properties are also easily modified to obtain very specific 
mechanical properties of the encapsulating hydrogel. Biodegradable moieties, degradation 
kinetics, and modulus are all very easily adjusted within this system. 
 Here, multiple applications of individual cell encapsulation are evaluated, including 
rare cell isolation for early cancer detection of circulating tumor cells, and mechanical 
protection for high resolution 3D bioprinting. We first review the current methods of cell 
surface modification and highlight the major applications of each technique as well as the 
potential disadvantages of each within our applications. Then, we looked into isolation of 
the highly sought after and rarely occurring circulating tumor cells (CTCs) for the potential 
of a fluid biopsy for cancer screening. Major challenges of isolating viable and functional 
CTCs are addressed, while also quantifying surface antigens of common cancer cell lines 
to find potential targets for isolation strategies. Commonly, surface biomarkers are either 
reported as positive/negative, as upregulated or downregulated expression levels. With the 
most common types of cell sorting methods relying on surface expression levels of 
phenotypic biomarkers, we quantify known metastatic markers in more translatable units 
of molecules/µm2, and fold over mononuclear blood cells (MNBCs) as opposed to ‘high 
or low’ as commonly reported. As detection of CTCs would depend on distinguishability 
of positive events from whole blood, markers must be chosen appropriately as to limit 
staining of MNBCs.  
4 
For the greatest efficacy in clinical applications, processing must be highly 
standardized and of sufficient scale to handle the volumes of blood and number of cells in 
such a fluid biopsy. To address the standardization of the polymerization process, we look 
to commercially available fluorescein. Fluorescein isothiocyanate (FITC) is a commonly 
used fluorochrome that is found commercially conjugated to a wide array of biorecognition 
molecules. Fluorescein belongs to the same family of xanthene dyes as the currently used 
initiator, eosin-5-isothiocyantate (EITC). We assess the potential polymerization power of 
using FITC vs EITC in both cellular studies as well as hydrogel film generation on micro 
array slides which model the cell surface. In order to ensure that this technology can handle 
the necessary volumes and cell numbers associated with clinical applications, we 
systematically analyze each parameter associated with the polymerization process. 
Parameters such as fluid volume/depth, variation in observed light intensity, chamber 
material, meniscus effects, and more were studied to determine what aspects of the process 
play the largest roles. This data may allow us to scale the process one to two orders of 
magnitude to very feasibly handle the fluid volumes associated with a fluid biopsy. 
We assess different applications of this same technology. Individual cell 
encapsulation provides membrane reinforcement protecting the cell from mechanical 
stimuli associated with fluid flow similar to that observed in high resolution 3D printing. 
With ultimate goals of printing viable organs for transplantation, high print rates are 
necessary to print on a feasible time scale while single cell resolutions are key to 
incorporating vasculature for sustainable viability. Pairing these two requirements 
drastically increases the shear forces observed with fluid flow through a pipe which can 
mechanically lyse cells hindering the viability of a printed structure. We study a range of 
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monomer formulations that result in polymer coatings that have vastly different mechanical 
properties. Coated and uncoated cells are subject to intense mechanical forces as they are 
extruded through a 50 µm diameter capillary at flow rates well above what is currently 
used in 3D bioprinting. We then correlate the protection potential of each of these polymer 
coatings with the observed mechanical properties of bulk hydrogels as well as the viability 
of cells upon extrusion. In the growing field of regenerative medicine, protection from 
inherent mechanical stimuli during the printing process is invaluable. 
The wide range of applications and standardized processing of single cell 
encapsulation makes this technology highly desired. Adaptation of the monomer coating 
for controlled biodegradation, or enhanced surface functionalization of the outer coating 
ensures that this technology is dynamic to the needs of future applications as the world of 
engineering and medicine evolve around us.  
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CHAPTER 2. BACKGROUND 
2.1 Protection 
Interest in cell surface modification primarily began in the 1980s with focus on 
harnessing pancreatic islets and their function for treating diabetes[1-3]. In cell therapeutics 
like islet transplantation, as well as any sort of allo- or xenographic transplant, immune 
response is a major concern. Upon injection of foreign cells, immune response of the host 
can eliminate injected cells through antibody recognition and macrophage recruitment 
which limits the efficacy of such treatments. T-lymphocytes or T-cells play a major role in 
cell-mediated immune response of foreign tissue through the recognition of major 
histocompatibility complex molecules found on the surface of nucleated cells. Currently, 
treatments to minimize host rejection are through drug mediated T-cell suppression. These 
drugs have major drawbacks including numerous side effects and chronic toxicity. As a 
physical alternative to immuno-suppressive drugs, research is being conducted in 
immunoisolation or immunocamouflage to accomplish similar goals [4, 5]. This concept 
was reported early on with the observation of continued functionality with polymer 
protected pancreatic islets [1, 2]. Modification or encapsulation of cells within a relatively 
bioinert material can protect the cells from a host immune response [5]. Polymeric 
networks with tuned mesh sizes can sterically prohibit large molecule permeability, such 
as antibodies, while still allowing small molecules such as oxygen and glucose to pass 
freely [1, 3, 6]. This allows the cells to remain viable and function normally while 
remaining hidden from natural immune responses of the host [3]. 
Since the initial focus on the transplantation of pancreatic islets, interest in surface 
modification has spread to many different cell types [7]. This concept of immunoisolation 
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has been thought to be a potential source for a universal blood ‘type’ or rather allowing 
any blood type to be received no matter the recipient’s type. The engraftment of bioinert 
molecules on the surface of red blood cells sterically blocks the host from recognizing the 
ABO antigens initiating an immune response against the donor blood [4]. A schematic of 
this concept is illustrated in Figure 2.1. In the early studies, cells were reacted with one end 
of long or bulky polymer chains. This was accomplished through covalent attachment of 
methoxypolyethylene glycol [5] or hyperbranched polyglycerols [8] with the commonly 
used N-hydroxy-succidimidyl ester (NHS). NHS reacts readily with primary amines found 
on proteins forming a covalent link. 
 
Figure 2.1: Schematic of immunoprotection by physical barrier from covalently bound 
hypderbranched polyglycerols to the cell surface from (a) antibody recognition, 
(b) immune cell interaction. 
 Many other types of surface modifications, including inorganic coatings, have been 
studied for their potential to protect the cell from harmful environments. Due to the lack of 
a structurally rigid cell wall, mammalian cells are far more susceptible to toxins and 
biological stimuli than many other cell types. Coatings have been developed to protect 
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these vulnerable cells from harsh stimuli such as oxidative stresses, enzymatic attack, and 
other cytotoxic molecules. In a similar manner to covalent immunoisolation, 
physiochemically adsorbed silica has been used to form a protective barrier on mammalian 
cells to protect them from enzymatic attack by trypsin and the cytotoxic agent 
poly(allylamine) hydrochloride [9]. An inorganic-organic hybrid coating has also shown 
protective potential of mammalian cells. Tannic acid binding to the surface of the cell 
followed by complexation with FeIII has shown protection from the cytotoxic agent 
polyethyleneimine, again through a physically formed barrier. This coating also provides 
protection from UV-C radiation due to the ability of tannic acid to absorb UV rays [10]. 
Surface modifications also have applications for protection against chemical stimuli by 
using reactive moieties in contrast to inert steric barriers. By functionalizing the surface of 
red blood cells with a known radical scavenger, (2,2,6,6-tetramethyl-1-piperidinyl)oxy 
(TEMPO), these cells were protected from oxidative damage in an in vitro model [11]. 
These red blood cells were functionalized with TEMPO through covalent coupling of NHS 
to primary amines of lysine groups found on the surface proteins of erythrocytes. 
2.2 Drug Delivery 
Functionalization of cellular surfaces extends from cell protection to drug delivery 
as well. The vast majority of drugs are currently delivered to target sites by passive 
transport through air ways and the circulatory system. With developments in nanoparticle 
systems, drug delivery has made great strides in recent years. However, passive transport 
is often accompanied by minimal targeting, short circulation time, and undesired systemic 
effects [12]. By harnessing the mobility and homing ability of living cells, drugs can be 
delivered more effectively through active transport increasing targeting ability and 
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retention time within the body [12, 13]. In this concept, the therapeutic agent is attached to 
the surface of cells by a degradable or diffusive polymer where it is carried directly to the 
site of interest for release, or is maintained in circulation for controlled release. 
As with applications in cell protection, the cell surface provides a range of 
biomolecules and functional groups to which nanoparticles or patches can be attached. The 
simplest method for cells to become drug carriers is through nanoparticle adsorption. 
Adsorption can be dominated by electrostatic interaction, hydrophobic interaction, and van 
der Waal forces depending on the particle being attached [7, 14, 15]. Living cells have a 
largely negative charge on the surface due to charged functional groups that make up the 
cell membrane. This negative charge creates a simple electrostatic attraction when using a 
cationic nanoparticle or polyelectrolyte multilayer patches [16]. The lipid bilayer of the 
cell presents a hydrophobic site within an aqueous environment for hydrophobic functional 
groups to favorably interact. Each of these functionalization methods are non-specific to 
cell phenotype. Through non-specific binding, polystyrene nanoparticles have shown 
greater retention times while attached to red blood cells (RBCs) than nanoparticles alone 
in vivo [14]. Non-specific adhesion to RBC surfaces has one advantage of allowing the 
surface of the nanoparticle to be functionalized with other delivery applications instead of 
purely for cell binding motifs. Nanoparticles for potential drug loading have also been 
covalently attached to red blood cells (RBCs) with minimal effects on clearance times and 
immunogenic pathways [8]. Hyperbranched polyglycerol (HPG) nanoparticles have 
similar biocompatibility as PEG due to their molecular similarities but do not have the 
potential recognition by PEG antibodies [17] found in some healthy patients. This is 
especially important for applications with goals of extended drug circulation time; antibody 
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recognition would clear functionalized RBCs at a much faster rate than unmodified or 
unrecognized cells. 
For a greater target specificity than is possible by passive transport, surface 
modification of homing cells is attracting significant attention [7, 18]. Cellular patches can 
be attached to the surface of living cells in similar ways to that of nanoparticles. Hydrogel 
patches have been successfully attached to the surface of living cells through localized 
photopolymerization [19]. Using initiator functionalized cells and a photomask, very small 
sections of cells can be exposed to radiation resulting in extremely localized hydrogel 
formation [19]. These patches have the potential to be loaded with small molecule drugs 
and carried to target sites by the mobility of cells. Homing cells such as macrophages and 
T cells are prime targets for drug vehicles [18, 20]. 
2.3 Isolation  
Surface modifications for high purity cell separation and isolation are more efficient 
when compared to specific culturing or density gradient centrifugation as they yield higher 
purities than gradient centrifugation and are completed in much less time than specific 
culturing. High purity cell isolation is a desired process in many applications including 
stem cell therapies, cellular function studies, and circulating tumor cell (CTC) isolation.  
 Of all surface modification strategies, antibody/antigen binding is the most 
common and most effective method of initial binding in applications of cell sorting from a 
heterogeneous population. Surface proteins and expression levels on cells vary drastically 
depending on species, phenotype, maturity and the surrounding environment [7, 21, 22].  
The heterogeneity and large number of surface markers introduces the ability to distinguish 
subtypes of cells within a mixed population through the highly specific binding of an 
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antibody to a particular surface antigen. Distinguishability of subtypes or rare populations 
becomes very difficult when the distinguishing antigen is expressed in low surface 
densities. Initial studies in our lab have shown that the stem cell marker CD34 on stem 
cells isolated from human cord blood can be as low as on the order of 10 molecules/µm2, 
while other phenotypic antigens such as epithelial cell adhesion molecule (EpCAM) on 
epithelial cells can have expression levels on the order of 103 molecules/µm2 [21]. When 
targeting cancer cells in peripheral blood, typically markers that are characteristic to the 
epithelial phenotype are chosen, such as EpCAM. However, tumor cells are believed to 
enter into circulation in part through a phenomenon known as the epithelial to 
mesenchymal transition (EMT). In addition to EMT, tumor cells are also believed to spill 
into leaky vasculature to create CTCs, which then often results in metastatic disease[23, 
24]. In applications of CTC isolation, efforts to better understand EMT are underway.[23-
28] In EMT, tumor cells go through a reversible process where they lose many of their 
adhesive epithelial traits and take on a more invasive mesenchymal phenotype. Whether 
this happens before entering circulation or once in the peripheral blood, the expression of 
the commonly targeted surface markers is decreased. The rarity of these cells paired with 
the change in surface antigen expression has made the enumeration, isolation, and 
functional study of these highly impactful cells very difficult. 
The two most common types of cell sorting methods currently being used are magnetic 
activated cell sorting (MACS) and fluorescent activated cell sorting (FACS). Antibody 
recognition is used for both of these sorting techniques to distinguish cell types in a mixed 
population. Each of these methods have their own advantages and disadvantages making 
them better suited for different applications. MACS has the primary advantage of high 
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sorting speed. Magnetic micro beads are functionalized with biorecognition molecules 
which are typically either a generic species’ secondary antibody or streptavidin.  The mixed 
cell population is first treated with a normal primary or a biotinylated primary antibody 
that is specific to only the target cell type. Once the primary has bound to the target cells, 
the magnetic microbeads are introduced to the system. Through the highly energetically 
favorable binding of primary to secondary antibodies, or biotin to streptavidin, magnetic 
microparticles bind to the surface of the cells creating a cell-bead complex of target cells 
that is susceptible to magnetic fields. Separation is then accomplished by passing the cell 
suspension through a column that is within in a strong magnetic field. Non-complexed cells 
pass through the column into a collection container, while antigen positive cells are 
retained at the wall of the column within the magnetic field. Finally, the column is removed 
from the magnetic field where antigen positive cells are washed from the column and 
collected. FACS uses the same type of antibody labeling to initially distinguish between 
target and non-target cells. Surface markers are labeled with fluorochromes rather than 
magnetic beads. Cell separation is achieved through the use of a flow cytometer. The flow 
cytometer uses microfluidic alignment of the cells to pass them through an excitation laser 
and analyze each cell individually for a range of fluorescent markers. After cells pass by 
the fluorescent detectors the microfluidic stream is then aerosolized into droplets 
containing individual cells. Droplets containing positive fluorescence are then 
electronically charged. The stream of droplets is passed through an electric field where 
droplets are diverted into separate containers based on their charge. The individual cell 
analysis and aerosolization for separation limits throughput of FACS. The initial labeling 
of the target antigen with its antibody is identical for each process. However, the sensitivity 
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and specificity, along with the overall processing time are vastly different. MACS has a 
much lower specificity than that of FACS. Magnetic separation has the risk of physically 
trapping non-target cells within clusters of target cells and magnetic beads. FACS has the 
ability to adjust the sensitivity and specificity of sorted cells. In flow cytometry, it is up to 
the user’s discretion to determine the cutoff of what fluorescent intensity is considered 
positive or negative. MACS has much less control. Sensitivity in magnetic separation is 
governed by the cell’s ability to remain bound to the magnetic bead as the beads are pulled 
toward the wall of the column and antigen negative cells pass through. This can become a 
major problem if the surface expression of the target antigen is low. Since FACS uses 
fluorochromes to detect antigen positive vs. negative cells FACS is not limited to surface 
antigens. If cell viability is not desired, fixation followed by permeation and fluorescent 
labeling allows for a wider range of intracellular phenotypic biomarkers to be used as 
potential targets. In practice, the majority of cell sorting applications require cell viability 
to be preserved for use or functional study of the target cells. 
 CellSeach is currently the only FDA approved method for clinical enumeration of 
CTCs. This system combines the MACS with flow cytometric analysis in order to 
enumerate CTCs for prognostic information in some cancers. Metastatic breast, prostate, 
and colorectal cancers have been shown to display poorer prognosis in patients that exhibit 
a CTC concentration above a given threshold. CTC concentrations >5 cells per 7.5 mL of 
blood for breast [29] and prostate [30] cancer, and >3 cells per 7.5 mL of blood for 
colorectal cancer [31] has been show to indicate a less favorable prognoses for these 
metastatic cancers. Along with the significance in CTC presence, the lack of CTC’s among 
healthy or non-metastatic patients highlights the fact that CTC specific to metastatic 
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disease, and supports the need for continued research of CTC behavior. Only 0.3% of 
healthy patients exhibit CTC concentration ≥2 CTCs in 7.5 mL of blood [32]. CellSearch 
first uses MACS as a pre-enrichment step. Magnetic micro beads functionalized with the 
antibody against EpCAM are used to positively select cells possessing characteristics of 
the epithelial phenotype. The collected cells following MACS are then fixed, 
permeabilized and intracellularly stained for cytokeratin and leukocyte common antigen 
(CD45). Cell analysis is achieved through the use of a Celltracks Analyzer II to identify 
cells that are positively fluorescent for cytokeratin, and are also negative for CD45. The 
Celltracks Analyzer II is an automated fluorescent imaging machine in which images of all 
positive events are obtained for confirmation by the operator. Pre-enrichment using MACS 
decreases the analysis time by reducing the number of cells to be analyzed by flow 
cytometry as well as visually, but it is still a limitation in the event that the process be 
scaled to larger batches. However, the largest problem with CellSearch is the lack of viable 
cells following isolation. Although this is a powerful tool for prognosis, it sheds no light 
on the functional properties of CTCs. This system serves its purpose of enumeration 
relatively well, but has no translation into further applications due to cell fixation. Pairing 
the statistical data of poor prognosis with the presence of CTCs and the absence of 
epithelial cells circulating in healthy patients, with the still uncertain mechanism of 
metastatic progression and EMT illustrates a need for an isolation technique that results in 
viable CTCs for further investigation as well as prognosis. 
2.4 Antigen Specific Lysis 
A novel cell isolation method has been developed in our lab that combines the 
benefits of MACS sorting speed, and FACS high purity sorting, called antigen specific 
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lysis (ASL) [33]. ASL uses surface initiated photopolymerization to encapsulate and 
protect specific cells from chemical lysis in the presence of harsh surfactants. Through the 
same utilization of primary antibody recognition, ASL preserves the same specificity as 
that of FACS for immobilization of a visual light photoinitiator onto the surface of target 
cells. Suspending the cell population in an acryloyl monomer solution containing a tertiary 
amine co-initiator followed by irradiation with 530 nm initiating light, results in rapid local 
polymerization fully encapsulating target cells. Once target cells are protected, the cells are 
subjected to harsh environments such as hypotonic conditions or surfactants that effectively 
lyse all antigen negative cells. This leaves behind essentially a 100% pure population of 
target cells. ASL provides the high throughput advantages of magnetic sorting and the same 
purity of fluorescent sorting all with relatively inexpensive materials. These traits make 
this technology highly desired in clinical applications of many sorts. The versatility of ASL 
is governed largely by cytocompatibility of the monomer solution. As regenerative 
engineering and cellular therapies continue to be highly researched, the choice of 
cytocompatible monomers is much less of a challenge than in previous years. PEG based 
monoacrylates and diacrylates (PEGMA and PEGDA) of many molecular weights, gelatin 
methacryloyl, alginate, poly(lactic acid), and more have been successfully used with living 
cells while maintaining cell viability [34-36]. A wide variety of monomer materials 
available for use with cells means that polymer properties can be highly tuned to desired 
specifications. Whether polymer mesh size, degradability, or hydrogel mechanical 
properties need to be tuned, simple adjustments in monomer formula can be made without 
significantly effecting processing time or targeting specificity. 
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The use of a visible light photoinitiator eliminates the possibility of UV mediated 
damage [37] to cell DNA. Eosin Y is a type II, photoinitiator that is excited by light that is 
530 nm; well out of the UV range. It is a member of a class of dyes derived from xanthene 
[38]. Apart from operating in the range of visible wavelengths, eosin is extremely powerful 
due to its ability to generate a large number of initiating radicals per fluorophore [39-41]. 
Type I photoinitiators are photocleavable molecules that degrade into two radical species 
[42] effectively limiting the molecule to a maximum of two initiated polymer chains. Once 
these radicals are terminated, polymerization ceases. Eosin however, has the ability to 
regenerate. Type II photoinitiators require a co-initiator to produce an active radical and 
allow the molecule return to its ground state without degradation[41]. A proposed initiating 
mechanism for eosin is first through the absorption of a photon electronically exciting the 
dye. The molecule undergoes a phenomenon called intersystem crossing from the singlet 
excited state to a triplet excited state. Here the initiator reacts with a co-initiator, commonly 
a tertiary amine, to yield radical species. It is believed that electron transfer from the tertiary 
amine to the excited eosin molecule followed by proton abstraction from the amine to the 
eosin results in two neutral radical species, a radical amine and an eosin radical [40]. Of 
these two, the radical amine is much more reactive to acrylate groups than that of the eosin 
radical and therefore is primarily responsible for the initiation of propagating chains [38, 
41]. Once initiation of a chain is achieved, propagation and termination proceed as normal 
free radical polymerization reactions. As the active chains propagate, the excited eosin 
radicals then return to the ground state where they can be excited to generate more amine 
radicals. Initiation will continue as long as irradiation continues and there are sufficient co-
initiator molecules in solution, until all eosin molecules are photobleached. While the eosin 
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initiator is tethered to the surface of the cell, the amine which becomes the amine radical 
is not. Diffusion of active radical species, and therefore monomer molecular weight, away 
from the cell surface plays a critical role in film formation. The curvature of the cell in 
relation to the film thickness and monomer lengths permits for modeling using a planar 
surface. Primary diffusion concerns are unidirectional away from the cell surface. If 
diffusion of active radical species away from the cell surface occurs at higher rates than 
chain propagation, polymer or oligomer formation may occur without achieving full 
encapsulation. A typical characteristic of free radical polymerization is the high reaction 
rate due to the high reactivity of most radical species. In our applications, monomers have 
a functionality >2 which results in a covalently crosslinked network. At high monomer 
conversion, the crosslink density or pore size within the network is greatly governed by the 
molecular weight of the major monomer species. The crosslink density determines what 
molecules may diffuse through the hydrogel film and what is restricted, which is critical to 
protection from surfactants as well as immune response in vivo. Termination is achieved 
by a few possible reactions. Active radical chains can undergo combination reactions with 
other active chains, radical initiating species, or radicals that are a result of chain transfer 
reactions. Active radicals can also be quenched by residual oxygen within the system, 
which is why the polymerization is carried out under an inert nitrogen atmosphere.  
This polymerization process and powerful initiating mechanism has proved 
very useful in sensitive detection of biomolecules on micro array slides. Polymerization 
based amplification (PBA) capitalizes on eosin’s ability to continue to generate radicals 
while under irradiation to form polymer films entangled with fluorescent nanoparticles 
for easy detection [43-45]. It has been shown on micro array slides that 
biomolecules can be 
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recognized in surface densities <0.2 molecules/µm2,and can amplify fluorescent signal by 
100 fold over standard fluorescent methods [43]. 
Figure 2.2: Schematic of the polymerization procedure for micro array and cell surface 
polymerization. 
For cellular applications, this translates to improved biorecognition of low 
surface expression antigens. Figure 2.2 illustrates polymerization process on micro 
arrays as well as cellular surfaces. Achieving full encapsulation while targeting low 
expression molecules is essential in CTC and stem cell isolation. Low expression 
levels for MACS or FACS results in poor magnetic bead binding or weak fluorescent 
signal to distinguish between positive and negative populations. Using the PBA system 
in ASL, we can overcome the surface expression challenge by adjustments in irradiation 
time and monomer formula. 
2.5 Mechanical Protection 
ASL technology provides mechanical protection in applications of bioprinting 
as well. Three-dimensional printing has gained substantial momentum in the past 
few decades. 3D printing of anatomical structures has been used in the medical field to 
better help visualize and understand complex morphologies in ways that a 2D depiction 
could not 
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capture. In surgical planning, imaging and subsequently printing target organs or anomalies 
of surgical interest allow for a more well-planned surgical process [46, 47].  More recently 
3D printing has been used with biomaterials to print cellular and acellular scaffolds for 
tissue engineering in regenerative medicine [48-54], 3D organ-on-a-chip platforms for in 
vitro drug screening [55, 56], and even functional prosthetics [57, 58]. As goals approach 
the printing of large scaffolds and whole organs, the need for high throughput and high-
resolution printing is evident. Mechanical forces are inherent in fluid flow and become a 
much larger issue on the microfluidic level when dealing with live cell printing. Many 
commercial bioprinters are extrusion-based printers that use pressure driven or 
mechanically driven flow to push fluid through a small orifice or nozzle in a direct-write 
fashion [59]. Shear forces are the forces created by a radial velocity gradient of the fluid in 
laminar flow through a tube. These shear forces increase with higher flow rate and smaller 
nozzle diameter, both of which are desired for whole organ printing. These shear forces 
have the ability to damage the membrane or completely lyse cells as they pass through the 
nozzle during printing. This is the largest disadvantage to extrusion-based printers and 
poses a problem to large, functional organ printing. Commonly, 3D cell printing is done at 
resolutions much greater than that of a single cell (150-300 µm nozzle diameter; epithelial 
cell diameter ~10-20 µm) at flow rates that are typically on the order of 1-10 µL/min [60-
63]. With these print rates it would take 102 days to print one large organ and still without 
achieving the necessary detail of high-resolution printing. To achieve the necessary detail 
involved with printing vasculature, single cell resolution is highly desired. Much work has 
been done to try to minimize shear forces experienced by cells such as altering print heads 
[64], using low viscosity bioinks [65] or using shear thinning fluids [63]. Printing 
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techniques have been able to print with high cell viability, but still with moderate resolution 
and relatively low throughput. More research must be done to achieve the resolution and 
throughput for plausible organ printing. 
 The same technology that provides protection against chemical stimuli for high 
purity isolation also has the ability to provide protection against mechanical forces. 
Through individual cell encapsulation, the hydrogel coating provides membrane 
reinforcement against mechanical stimuli. As cells travel through a narrow tube, the shear 
forces create a tensile strain on the cellular membrane. In high flow rates the tensile strain 
becomes more than the membrane can withstand causing cell lysis. Hydrogel coatings 
possessing the proper mechanical properties support the membrane allowing the cells to 
remain intact upon intense shear forces. 
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CHAPTER 3. MATERIALS AND METHODS 
3.1 Poly(ethylene glycol) diacrylate synthesis 
 Synthesis of poly(ethylene glycol) diacrylate was performed as described 
previously [33]. For PEGDA 3400 25 g of poly-(ethylene glycol) (PEG; Mn ~3000-3600 
Sigma) were added to a round bottom flask and purged with ultra-pure nitrogen for 10 min. 
Anhydrous dichloromethane (DCM; 75 mL) was added to the flask and PEG was allowed 
to dissolve under magnetic stirring for 5 min. A water bath was used as a heat sink for the 
round bottom flask while stirring continued. Triethylamine (TA; Sigma) and acryloyl 
chloride (AC; Sigma) were used with PEG in a 1:4:4 mole ratio of PEG:TA:AC. TA (4.25 
mL) was added directly to the dissolved PEG under continuous stirring. AC (2.4 mL) was 
mixed with DCM (12.4 mL) and added to the top of the addition funnel by injection through 
a septum and purged with nitrogen for 15 min. AC/DCM was then added dropwise to the 
PEG/TA/DCM mixture at a rate of ~ 1 drop every five seconds under continuous stirring 
and nitrogen purging. Once all of the AC/DCM was added, the flask was sealed and 
covered with foil to react overnight under continuous stirring. The reaction mixture was 
then filtered through a Buchner funnel and washed with excess DCM to remove insoluble 
TA salts. Then 10-fold molar excess sodium carbonated was added to the mixture and 
stirred for 1 hour, followed by filtration through a Buchner funnel and washed with DCM 
removing any insoluble sodium carbonate. The solution was then passed through a bed of 
alumina (Sigma, ~ 3-5 cm thick) in a glass frit column and washed with DCM. The DCM 
was evaporated off using a rotary evaporator until ~ 50-100 mL of DCM remained. 
PEGDA was precipitated out using ~ 10 x the DCM solution volume of cold ether. Solution 
was kept at 4 ˚C for 1 h to ensure precipitation. Precipitated solids were collected by 
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filtration with a Buchner funnel and allowed to dry in the dark, under vacuum overnight. 
Precipitation in cold ether was repeated for further purification as needed. Polymer 
structure and acrylation was determine by H1 NMR (DMSO). Acrylation was confirmed 
by the characteristic peaks for the three hydrogens bound to the carbon-carbon double bond 
of the acrylate functional group. PEGDA 1000 (PEG Mn ~950-1050; Sigma), and PEGDA 
2000 (PEG Mn ~1900-2200; Sigma), were synthesized following this procedure using the 
same reagent equivalents. 
3.2 Cell culture  
All cell types were cultured in medium supplemented with 10% FBS (VWR) and 
1% penicillin/streptomycin (VWR) at 37 ˚C and 5% CO2. H9C2 (ATCC CRL-1446) rat 
cardiac myoblasts were cultured in Dulbecco modified eagle medium (DMEM, HyClone). 
Human non-small-cell-lung cancer lines (A549 and H358; ATCC CCL-185 and ATCC 
CRL-5807 respectively) and human breast cancer lines (T47-D, MCF-7, MDA-MB-231; 
ATCC HTB-133, ATCC HTB-22, ATCC HTB-26 respectively) were cultured in Roswell 
Park Memorial Institute (RPMI 1640) medium.  
Cells were seeded in 75 cm2 tissue culture flasks (VWR) for 24-72 h and were 80-
95% confluent prior to use. Cells were harvested using 0.25% Trypsin-EDTA 1X (VWR) 
for 90 s. Then, cells were collected and washed with 5 mL medium to neutralize the trypsin. 
Cells were centrifuged at 4 ˚C and 400 x g for 3 min, supernatant was aspirated and cells 
resuspended in 1 mL PBS for one wash. Cells were washed twice and resuspended in PBS 
(HyClone) for processing. 
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3.3 Viability assays 
 Cell viability was assessed through multiple methods. Metabolic activity was 
assessed through the use of the MTT assay. The MTT assay is a colorimetric method used 
to measure mitochondrial activity within the cell giving information on viability and 
proliferation relative to a control group of unprocessed cells. 3-(4,5-dimethylthiazol-2-ly)-
2,5-diphenyltetrazolium bromide (MTT; Thermo) is a water soluble dye that in the 
presence of active mitochondrial reductase is reduced into (E,Z)-5-(4,5-dimethylthiazol-2-
ly)-1,3-diphenylformazan (formazan), a water insoluble dye. An equal number of cells 
(~10,000) from each sample were incubated in 200 µL of medium with 0.45 mg/mL MTT 
for 3-4 hours at 37 ˚C (n ³ 3 for each sample). All separate samples were measured in a 96 
well plate (Celltreat). After incubation, the plate was centrifuged, wells were aspirated and 
well contents were solubilized in 200 µL of DMSO (Sigma). Absorbance of 570 nm light 
for each well was measured using a Biotek plate reader. Absorbances for each sample were 
averaged and normalized to control cells for relative viability. 
 Viability by membrane permeability was measured using ethidium homodimer-1 
(EthD-1; Thermo Fisher). EthD-1 is a large, membrane impermeable dye that binds to 
nucleic acids. It is a red fluorescent dye that is weakly fluorescent until bound to the 
nucleus. Due to size of the molecule, the dye is only able to permeate the membrane of a 
dead or damaged cell. Healthy cells with complete membrane integrity will show little or 
no fluorescence. EthD-1 assays were conducted at a concentration of 2 µg/mL with cells 
in PBS at room temperature for 5 mins. Viability was assessed by fluorescent microscopy 
and flow cytometry.  
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3.4 Cell tracking 
 Syto 62 deep red nuclear stain was utilized for cell tracking through cell processing. 
The Syto dye is a membrane permeable nucleic acid stain which allowed for better accuracy 
during processes that involved cell membrane fragmentation. This stain was used at 1 
µg/mL for 5 min on ice. Cells were then washed 2x in PBS before further processing. 
3.5 Micro array printing 
 As a model of the cellular surface protein expression, biotin printed micro array 
slides were used. Biotinylated bovine serum albumin (bBSA; Thermo Fisher) was printed 
in serial dilutions of 1000, 400, 160, 64, 25.6, and 0 µg/mL. All dilutions were made with 
a 1000 µg/mL solution of bovine serum albumin (BSA; Sigma) in PBS (PBSA) in order to 
keep the total protein concentration constant at 1000 µg/mL. Micro arrays were printed 
using an Affymetrix 417 Arrayer, and Array It epoxy coated microscope slides at 60% 
humidity. Each micro array consisted of six columns of the different bBSA concentration, 
with each printed four times to make up a 4x6 array. Two arrays were printed on each slide 
to be centered within the wells of the Whatman chip clip slide holder. Once printed, slides 
were placed back in slide boxes away from light to dry for >12 hours under ambient 
conditions. One slide from each batch was analyzed using a streptavidin-Cy3 (SA-Cy3; 
Thermo Fisher) conjugate and micro array scanner. SA-Cy3 labeling was performed as 
described below for SA-EITC labeling with a working solution of 20 µg/mL SA-Cy3 in 
PBSA. Slides were scanned on a Affymetrix 428 Array Scanner using the 532 nm laser 
line and 570 nm absorbance. Fluorescent intensities were compared to a Cy3 calibration 
slide to ensure successful and consistent bBSA printed surface densities.  
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3.6 Micro array polymerization 
 Biotinylated BSA (bBSA) slides were placed in a Whatman chip clip side holder 
for processing. Each well of the micro array slide was processed one at a time to ensure no 
photo-bleaching of the photo-initiator. The well was first washed with 400 µL of 1 mg/mL 
BSA in PBS (PBSA) to remove any unreacted bBSA. A blocking step was then performed 
by incubation of 400 µL of PBSA for 40 min at room temperature, covered from light. 
bBSA printed arrays were functionalized with streptavidin-eosin isothiocyanate (SA-
EITC) or streptavidin-fluorescein isothiocyanate (SA-FITC) by incubation with 400 µL of 
~30 µg/mL SA-EITC or SA-FITC in PBSA for 30 min covered from light. Following 
initiator labeling, the well was washed 3x with PBS to remove any unreacted SA-EITC. 
PEGDA (Mn = 575, 700, 1000, 2000, 3400) monomer formulations were as follows: 25% 
wt/v PEGDA, 35 mM triethanol amine (TEA; Sigma), and 35 mM vinyl pyrrolidinone (VP; 
Sigma). PEGDA Mn 575 and 700 were purchased from Sigma, while Mn 1000, 2000, and 
3400 were synthesized in house based on published protocols [33]. 350 µL of monomer 
solution were place in the chip clip well prior to irradiation. The chip clip was placed inside 
a polymerization chamber constructed of two petri dishes and purged with ultra-pure 
nitrogen for 5 min at 0.8 standard L/min. Nitrogen was bubbled through water prior to 
entering the purging chamber to decrease evaporation of the aqueous monomer solution. 
After purging, nitrogen flow rate was reduced to 0.2 standard L/min to further reduce 
evaporation of the sample. Irradiation was achieved using two possible sources, both at the 
same intensity of ~35 mW/cm2, for 10 min. One lamp is a small, collimated LED (M530L3, 
Thorlabs) and the other is a large LED array lamp (Photon System Instruments). Both 
lamps are green LEDs centered near 530 nm. Following irradiation, slides were removed 
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from the chip clip, washed with DI water, and allowed to dry over-night before further 
analysis.  
3.7 Profilometry 
Profilometry gives topographical information in very fine resolution. Here we 
used it to measure step height of the film generated in localized polymerization in micro 
arrays on initiator labeled spots. Micro arrays were polymerized and allowed to dry for 
>12 hours before profilometry on a Daktek 6M Profilometer. Profilometer scans were 
done on all four spots for each individual bBSA print concentration. Profilometry uses 
optics to measure deflection angle of light from a cantilever in contact with the surface of 
the sample. Scans were done at 1 mg of force with a scan rate of ~40 µm/s. Scans were 
zeroed on both sides of each spot before measurement. 
3.8 Streptavidin-fluorophore conjugation 
The photoinitiator, eosin isothiocyanate (EITC), was conjugated to the 
biorecognition molecule, streptavidin (SA) as reported previously [66]. First, 0.1 M sodium 
bicarbonate (pH ~8.3) was mixed with 0.1 M sodium carbonate (pH ~11.3) to obtain a 
carbonate buffer of pH 10.2. Then 95 µL of 10 mg/mL SA in carbonate buffer was mixed 
with 9.5 µL of 10 mg/mL EITC in DMSO. The mixture was covered from light and placed 
at 4 ˚C for 8-12 h. The mixture was then diluted with 1 mL PBS before purification. The 
SA-EITC conjugate was purified by passing through a 7 kDa molecular weight cut off 
desalting column (Zeba Spin, Thermo Fisher). Conjugate ratio was determined using UV-
VIS absorbances at 530 nm and 280 nm (NanoDrop 2000, Thermo Scientific). Using 
standard absorbance curves of SA and EITC alone, absorbance corrections were made and 
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ratios were calculated as described previously [66]. Typical SA-EITC ratios range from 4-
6 EITC molecules per SA. Chapter 5 experiments containing SA-FITC and SA-Cy3 were 
processed identically measuring absorbances at 495 nm and 550 nm respectively. 
3.9 Cell encapsulation 
Cells were cultured and harvested as described above. The polymerization 
procedure was the same for all cell lines unless stated otherwise. Samples were split into 
1.5 million cell aliquots for encapsulation. Biotin was covalently labelled to cell surface 
proteins using a biotin-succinimidyl ester conjugate (NHS-biotin; EZ-link Sulfo-NHS-LC-
Biotin, Thermo Fisher). Cells were incubated in 250 µL of 0.55 mg/mL NHS-biotin for 40 
min on ice, then washed 3x in PBS. Eosin was then conjugated to the cells using an in-
house synthesized streptavidin (Thermo Fisher)-eosin isothiocyanate (EITC, Sigma) 
conjugate (SA-EITC, as described above). Cells were incubated in a PBS solution of ~30 
µg/mL SA-EITC for 30 min on ice covered from light. The sample was then washed 3x in 
PBS before introduction to the monomer solution. After the final wash in PBS, cells were 
pelletized, aspirated, and resuspended in 350 µL of monomer solution. PEG based 
monomer solutions were all the same as described for micro array polymerization 
above. Gelatin methacryloyl (gelMA) monomer formulations contained 3% wt/v gelMA, 
1 % wt/v PEGDA 3400, 35 mM TEA, and 35 mM VP.  All monomer formulations were 
adjusted to pH 7.3-7.5 for use with living cells. This monomer/cell suspension was 
transferred to a chip clip (Whatman) containing a glass slide and placed in a chamber 
constructed of two 150 mm clear polypropylene tissue culture dishes. This chamber was 
purged with nitrogen with a water bubbler for 5 mins at 0.8 standard L/min before 
irradiation. During irradiation, nitrogen was reduced to 0.2 standard L/min to reduce 
evaporation of the sample. Cells were 
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irradiated with a 530 nm collimated LED lamp (Thorlabs) at 35 mW/cm2 for 10 min for 
the surface polymerization reaction. After polymerization, cells were removed by pipette 
and the chip clip was washed 2x with 500 µL PBS. The glass slide was then removed and 
scraped with a cell scraper to ensure maximum cell recovery. Cells were washed 2x in PBS 
and strained with a 40 µm cell strainer (VWR) to remove any cell aggregates and bulk 
polymer particles prior to further processing. 
3.10 Hypotonic Challenge 
Hypotonic challenge was performed on cells for proof of encapsulation. Cells 
without membrane reinforcement will swell and burst in the presence of pure water, while 
fully coated cells will remain intact. Cells were centrifuged and aspirated, then resuspended 
in DI water at ~ 20,000 cells/mL. Cells remained in DI water for 10 mins at room 
temperature. Tonicity balance was restored using 10x PBS before flow cytometry or 
viability analysis. 
3.11 Surfactant Challenge 
Surfactant challenged cells were suspended in PBS prior to introduction of Sodium 
dodecyl sulfate (SDS) or Triton-X (TX) 100 (both Sigma). A 10% wt/v solution of SDS, 
and a 5 mM solution of TX in PBS were made as stock solutions. Surfactants were 
introduced to the suspended cells in a 1:2 dilution. Cells observed surfactant concentration 
was 5% wt/v for SDS and 2.5 mM for TX, which are 20x and 10x the concentration of the 
critical micelle concentration respectively. Cells were incubated in a particular surfactant 
solution for 10 min at room temperature. Cells were then centrifuged, aspirated and washed 
with PBS before flow cytometry or viability analysis.  
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3.12 Extrusion 
 High throughput, high-resolution cell printing was simulated by extrusion of a cell 
suspension through a 5 cm long, 50 µm diameter capillary (IDEX Health and Science). 
Protection potential of each monomer formulation was determined by percentage of intact 
cells following extrusion through the capillary. The capillary was fixed to a luer lock by 
compression fitting and attached to a 1 mL syringe (BD Biosciences). The syringe was 
loaded with 0.5-1 million cells in 1 mL of PBS, placed in a syringe pump (Harvard 
Apparatus) and turned upright so that the syringe was held vertically. The syringe pump 
extruded the contents of the syringe at 4.8 µL/s into an open microcentrifuge tube (VWR). 
Following extrusion, cells were analyzed by flow cytometry (Accuri C6) using forward 
scatter and side scatter gating to determine whole vs. lysed cells both before and after 
extrusion, as well as all viability assays mentioned above. 
3.13 Shear without pressure change 
 To observe the effect of shear forces on coated and uncoated cells in the absence of 
a pressure drop, a parallel disc viscometer was used (DHR2, TA Instruments). Cell 
suspensions were loaded onto the bottom disc of the viscometer and the top disc lowered. 
Viscometer studies were performed at a 30 µm gap and a 300 rad/s angular velocity, with 
an exposure time of 10 s. Shear stress was measured by the instrument at ~110 Pa during 
each run. Cells were then collected and analyzed by flow cytometry and EthD-1 viability 
and MTT assays to determine the protective potential for each monomer solution against 
uncoated cells. 
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3.14 Rapid Pressure Drop 
Cells were subject to high pressures and rapid decompression simulating the pressure 
changes extruded cells experienced in the absence of shear forces. Suspended cells were 
placed in micro centrifuge tube at similar concentrations to extruded solutions. The open 
centrifuge tube was placed inside a pressure chamber (Parr Instrument Company) and 
charged with nitrogen to pressures above and below those experienced during the extrusion 
process (8-25 bar), followed by sudden decompression back to atmospheric pressure. 
Pressure was held constant for two separate lengths of time. First, cells were exposed to 
these high pressures for ~2 min to simulate similar time scales of the extrusion process 
above. Separate samples were then held at high pressures for ~10 min to determine if longer 
exposure times would affect cell viability. Cells were then analyzed through flow 
cytometry to determine whole vs. lysed cells, as well as all viability assays mentioned 
above. 
3.15 Mechanical properties 
The swelling ratio of each polymer was determined in deionized water (DIW). 
Monomer formulations were supplemented with 1 mM EITC in DMSO at a 1:10 dilution 
for a final EITC concentration of 0.1 mM. Each sample was subjected to the same nitrogen 
and irradiation conditions as cell coating experiments above. Bulk gels were formed in a 
chip clip on a glass slide using a 16 well clip. 75 µL of monomer solution were placed in a 
well for polymerization. The chip clip containing the monomer solution was then irradiated 
with 530 nm light for 10 minutes. Upon the formation of bulk hydrogel, the gel was placed 
in 4 mL of DIW for 4-8 hours on a rocker table to allow for complete saturation. Gels were 
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removed from water, patted to remove excess water and weighed in their swollen state. All 
gels were then placed under vacuum for ~24 h and weighed again in their dry state. 
Unidirectional tensile testing was also performed on each polymer type. Films were 
generated in 9 x 9 cm square tissue culture dish at ~1 mm thickness. Gels were placed in 
water for 24 h prior to testing. Test samples were stamped out of the film in a ‘dog bone’ 
shape (5 mm width at center) and each end glued to glass slides with cyanoacrylate super 
glue (HDX). PEGDAs 700, 1000, 2000, and 3400 were tested on an Instron tensile tester. 
GelMA/3400 was too soft for the limits of the commercial tensile tester and therefore was 
tested using an in house designed tensile tester composed of a step motor (Oriental Motor 
Co.) and 10 g load cell (Transducer Techniques). Initial length and film thickness were 
measured by digital calipers before force was applied. Tensile strength was measured as 
the film was stretched at a rate of 4 mm/min until failure. Stress/strain curves were 
generated and modulus, ultimate tensile strength, and percent elongation at failure were 
calculated. 
3.16 Flow cytometry 
Flow cytometry analyses were done on an Acuri C6 table top cell analyzer. Flow 
cytometry was used to observe cell size, morphology, and fluorescent characteristics of 
cellular events. With this machine light scattering properties as well as fluorescent 
properties from four different wavelengths are recorded for each individual event analyzed. 
Cells suspended in PBS are pulled up into the machine by a sip and peristaltic pump. Micro 
fluidic channels then funnel the sample down using a sheath fluid to pass the cells one-by-
one through the laser. Optical detectors are placed directly in line with the incident light on 
the opposite side of the fluid sample and perpendicular laterally to the laser. Size and 
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morphology information is obtained from forward scattered light (FSC) to the inline 
detector and side scattered light (SSC) to the perpendicular detector respectively. Four light 
detectors with different optical filters collect information regarding fluorescent intensity of 
the specific wavelength. All optical information is recorded for each event processed. This 
powerful tool gives quantitative information regarding cell viability when using the 
fluorescent viability assays mentioned above. EthD-1 and Calcein dyes are easily analyzed 
quantitatively through the use flow cytometry and fluorescent filters. Intact cellular events 
were determined by FSC and SSC values compared to control samples before particular 
processes.  
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CHAPTER 4. QUANTITATIVE ANALYSIS OF SURFACE MARKERS FOR CTCS AND CURRENT 
ISOLATION STRATEGIES 
4.1 Introduction 
 Metastatic cancers are by far the most deadly form of malignant tumor, attributing 
to more than 90% of cancer related deaths [26, 67]. Metastasis occurs when cells from the 
primary tumor make their way into circulation before reaching and colonizing distant 
tumor sites [67]. These circulating tumor cells (CTCs) have been intensely studied since 
the first observation in 1869 [68]. The presence of these CTCs in cancer patients introduces 
the potential of a fluid biopsy for cancer screening. Such a biopsy comes with major 
advantages of minimally invasive acquisition, early diagnosis, and greater depth of 
prognostic information. Solid tumor biopsies can be painful and have associated risks of 
invasive procedures. A fluid biopsy that could be achieved through a standard peripheral 
blood draw would have great clinical utility. Early diagnosis and treatment of cancer 
patients has been shown to greatly increase the treatment efficacy and survival rates [69, 
70]. CTC presence is believed to occur at very early stages of cancer. By the time that a 
solid tumor is large enough to be observed on a scan, the patient may have had CTCs for 
>10 years [71]. Rare cell isolation techniques are an area of intense study due to multiple 
applications in CTC isolation, stem cell isolation, and the ability for functional 
characterization of these highly impactful populations. The extreme rarity of these CTCs 
along with evidence that suggests multiple, distinct populations can arise from a single 
tumor primary with variable phenotypic profiles [72-74], greatly hinders current isolation 
strategies from accurately isolating functional cells. 
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4.1.1 Current Isolation Strategies 
Viable cell sorting is highly desired in clinical settings as well as for cell biology 
research. Many current methods are affinity based and use specific cell surface molecules 
to distinguish rare populations or subtypes from the rest of the sample [75]. These methods 
are considered passive strategies. Separation is achieved by immobilization or deflection 
of target cells away from the general flow within microfluidic devices. Nagrath et al 
developed a CTC isolation chip that immobilizes CTCs without the need of any pre-
labeling or processing of cells [76]. This microfluidic chip contains micro posts coated 
with antibodies against epithelial cell adhesion molecules (EpCAM), a commonly targeted 
antigen for CTCs. Whole blood flows through the chip at controlled laminar conditions 
where cells expressing EpCAM are bound and then collected by elution [76]. Another label 
free microfluidic device uses molecule specific affinity in ‘deterministic cell rolling’ to 
isolate target cells [77]. Antibody or protein functionalized grooves initiate cell rolling with 
a slightly orthogonal trajectory to the fluid flow, separating positive cells from the rest of 
the population where they are collected. This method has been shown to isolate a number 
of cell types from a heterogenous population with high purity (>90%) [77] . Deterministic 
cell rolling has shown promise of high purity but has not been used for CTC isolation. 
While many of the affinity based microfluidic methods are able to achieve relatively high 
purity, it comes at the expense of processing speed. Many of these devices operate on the 
order of 10 µL/min [75-77]. 
 Magnetic activated cell sorting (MACS) relies on cell surface functionalization 
with magnetic micro beads. Magnetic beads coated with biorecognition molecules, 
commonly antibodies, are incubated with heterogenous the heterogenous cell population. 
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Antigen positive cells bind with these particles making them susceptible to a magnetic 
field. The entire population is then passed through a column in the presence of a strong 
magnetic field. Antigen positive cells are retained at the walls of the column while all other 
cells pass through freely. The magnetic field is then removed to collect the antigen positive 
population. While MACS offers a great advantage of high throughput processing up to 1011 
cells in 30 min [75], the isolation purity is much lower than that of alternate strategies. The 
product purity of MACS is highly dependent on the abundance of the target cell in the 
original population [78]. It has been shown that target cell populations of 1% have yielded 
only 37% purity following MACS [79]. For this reason, MACS is often used as a pre-
enrichment step before processing with another isolation method. Depending on the 
application of the sorted cells, removal of the magnetic micro beads may also be required. 
 Fluorescent activated cell sorting (FACS) has been widely used in cell separations 
due to its high purity sorting abilities. FACS uses fluorescent labeling in much the same 
way as MACS uses magnetic labeling. Fluorochromes are bound to cells by target cell 
specific antibodies. Using microfluidics, the cell suspension is funneled down to a single 
cell stream where it passes through excitation lasers and optical detectors to determine 
fluorescently labeled cells. The cell stream is then aerosolized and droplets are charged 
based on their fluorescent characteristics. Droplets are passes through an electric field 
where they are directed to different containers based on their charge and therefore their 
fluorescent properties. In viable cell sorting with FACS surface antigens are used for 
fluorochrome labeling, as opposed to intracellular staining. The surface expression of the 
target antigen is a critical factor in cell sorting ability.  
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 CellSearch is currently the only FDA approved technique for CTC enumeration. 
CTC abundance in peripheral blood has been shown to have significant impact on 
prognosis for some cancers [29-31]. This method combines the high throughput enrichment 
of MACS with fluorescent labeling of characteristic markers for distinguishability of 
CTCs. MACS enriched populations are fixed and permeabilized for intracellular staining 
of the nucleus and cytokeratin, while also staining for leukocyte common antigen, CD 45. 
Events are considered positive when nucleated, positive for cytokeratin and negative for 
CD 45. While this method is a powerful tool for CTC enumeration, it does not yield viable 
cells and therefore has little translation to functional CTC analysis or rare cell isolation 
applications where viability is necessary. 
 As many these methods may possess the potential for viable CTC isolation in a 
clinically relevant fluid biopsy, surface expression of target cells greatly dictates efficacy 
of antibody based techniques. Low surface expression, or more quantitatively, surface 
density of target markers decreases the binding of fluorochromes or magnetic beads over 
non-specific binding hindering the distinction between positive and negative events. For 
passive isolation techniques, low molecule surface density translates to lower binding 
affinity leading to decreased retention or rolling initiation of target cells. Currently, the 
literature contains very little quantitative information regarding surface expression. Most 
reports for common metastatic markers are given as positive/negative or 
upregulated/downregulated. Quantitative reports by enzyme immunoassay and enzyme-
linked immunosorbent assay are in units of mass of protein per mass of cell lysate. These 
assays measure total antigen presence of lysed and homogenized cells which include 
intracellular expression. While this information may be valuable in alternative applications, 
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viable isolation techniques rely only on surface expression. In this chapter we quantify the 
surface expression of common cancer related biomarkers. 
4.1.2 Common Surface Markers Associated with Metastasis 
 As most primary tumors are composed of adherent epithelial cells, it is obvious that 
most strategies target common epithelial markers. Of these, epithelial cell adhesion 
molecule (EpCAM) is by far the most widely used in the literature. EpCAM is a calcium 
ion-independent surface protein which is primarily involved in homophilic cell-to-cell 
adhesion [80]. EpCAM has been shown to have upregulation of two to three orders of 
magnitude in breast cancer tumors as opposed to healthy tissue [81]. While the targeting 
of EpCAM on CTCs is highly prevalent, problems can occur such as EpCAM negative 
cancers, and downregulation or loss of epithelial characteristics upon EMT and entering 
circulation. 
 In breast cancer, three highly targeted biomarkers are human epidermal growth 
factor receptor 2 (HER2), estrogen receptor (ER), and progesterone receptor (PR). These 
three markers are used to classify subtypes of breast cancer for therapy selection and 
prognostic information. HER2 is a tyrosine kinase that forms heterodimers with other 
markers in its family to increase cell division [82, 83]. ER binding with the hormone 
estrogen plays a role in promoting proliferation of mammary cells. Upregulation of ER is 
believed to be associated with over proliferation and/or formation of genotoxic by-products 
[84]. PR is transcription protein that when activated by progesterone controls the regulation 
of specific genes. 
 E-Cadherin and N-Cadherin are adhesion molecules that play different roles in 
metastasis. E-Cadherin is a calcium-dependent molecule that plays a role in homotypic 
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cell-to-cell adhesion. Decreased expression of E-Cadherin is thought to be one of the first 
steps in the metastatic progression [85] as well as EMT [86] by decreasing cell adhesion to 
the primary tumor. N-Cadherin is also a calcium-dependent homotypic cell adhesion 
molecule, but is also believed to be responsible for detachment mechanisms [87]. 
Expression of N-Cadherin has been associated with more invasive cancers [87, 88]. 
 CD44 and integrin αVβ3 are both biomarkers that are adhesive to the extracellular 
matrix (ECM). CD44 is a transmembrane protein that is activated by hyaluronan to 
stimulate intracellular functions associated with metastasis, including adhesion, migration, 
and invasion [89, 90]. Integrins are a family of adhesion molecules that play roles in 
migration, survival, and activation of apoptosis suppressors [91]. Within this family, 
integrin αVβ3 has been identified as an important marker in early angiogenic activity, 
tumor growth, invasion and metastasis [92, 93]. 
 Intercellular adhesion molecule 1 (ICAM1) is another adhesion molecule positively 
expressed in breast cancer [94, 95], that has roles in cell morphology, cell-to-cell adhesions, 
and migration [96] . Expression of ICAM1 found on CTC suggests that it may play a role 
in metastasis by promoting migration of cells through the ECM [96]. A major part of 
metastasis is also the ability to initiate tumor growth and sustain transport of nutrients 
through angiogenesis. Epidermal growth factor receptor (EGFR) is a member of the 
tyrosine kinase family and plays a significant role in angiogenesis, proliferation and 
apoptosis resistance apoptosis [97]. Positive expression of EGFR has been linked to less 
favorable prognoses over EGFR negative tumors in breast cancer [98].  
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4.2 Materials and Methods 
4.2.1 Peripheral Blood 
A peripheral blood sample was obtained with informed consent through University 
of Kentucky Medical Center IRB protocols and processed within an hour of collection. 
Whole blood was mixed with dextran and NaCl to a working concentration of 2 wt/v% 
dextran and 0.3 wt/v% NaCl and was allowed to separate by 1 x g in ambient conditions 
for 1 hour. The buffy coat containing peripheral blood mononuclear cells (PBMC) was 
then pipetted off and exposed to a red blood cell lysis buffer (155 mM NH4Cl, 10 mM 
KHCO3, 0.1 mM EDTA) for 5 minutes to further remove red blood cells from the sample. 
Nucleated cells were collected by centrifugation at 300 x g for 5 minutes and washed twice 
with cold 1 X PBS. 
4.2.2 Surface Marker Immunostaining 
Tumor cells were cultured and harvested as described in Chapter 3.2. Cell 
concentration and mean cell diameter was determined optically with a Cellometer 
Automated Cell counter (Nexelcom). Each replicate sample consisted of 1 x 105 cells in a 
microcentrifuge tube. For experimentation, a rinsing buffer of 1 X PBS with 3% FBS was 
prepared and used for all rinsing steps. All materials and cell samples were kept on ice 
throughout the staining procedure. For immunolabeling, samples were incubated with 
primary antibodies at ~ 0.5 µg in 150 µL of rinsing buffer for 40 minutes. For all cell lines, 
markers were targeted with primary monoclonal mouse antihuman IgG antibodies with 
corresponding isotype controls that consisted of: CD326/EpCAM (IgG2b, clone 9C4, 
BioLegend, San Diego, CA), HER1/EGFR (IgG1, clone AY13, BioLegend), CD44 (IgG1, 
clone BJ18, BioLegend), E-cadherin (IgG1, clone 67A4, BioLegend), erbB2/HER2 (IgG1, 
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clone 24D2, BioLegend), N-cadherin (IgG1, clone8C11, BioLegend), αVβ3 integrin 
(IgG1, clone 23C6, BioLegend), ICAM-1 (IgG1, clone HA58, eBiosciences, San Diego, 
CA), ER-α (IgG2a, clone F-10, Santa Cruz Biotechnology, Dallas, TX). Samples were then 
rinsed twice with rinsing buffer. Cells were then incubated with biotinylated goat anti-
mouse IgG antibody (Vector Labs, Burlingame, CA) at a 1:400 dilution in rinsing buffer 
on ice for 40 minutes. Cells were rinsed twice and incubated with streptavidin-
phycoerythrin at ~ 1 µg in 200 µL on ice for 20 minutes. Samples were rinsed three times 
and resuspended in ~ 200 µL for immediate analysis with flow cytometry. 
4.2.3 Data Analysis 
Data was calculated as mean ± standard error of the mean (n=3) for all marker 
quantification assays and cell diameter calculations. Standard error was used to as opposed 
to standard deviation due to the large variance in fluorescence within a single replicate. 
The standard error illustrates how our observation relates to the true mean of marker 
expression. Quantibrite PE bead calibration was performed every day of cell 
immunofluorescence data collection and fluorescence calibration values were collected 
using a 585/40 bandpass filter for red-orange detection. PE per cell values were calculated 
using a linear calibration curve (R2 ~0.98) of PE molecules vs. fluorescence generated from 
the bead calibration for each on their respective days of collection. Statistical analysis 
consisted of a two-tailed student t-test performed in Matlab to calculate p-values. 
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4.3 Results 
4.3.1 Image analysis 
 Morphological comparison of cell lines studied are shown by bright field images in 
Figure 4.1. The distinct morphology of the MDA-MB-231 basal like breast cancer cell line 
[99] from the other lines studied is present in the elongated, multipolar nature with minimal 
cell-to-cell contact. This morphology is characteristic of basal subtypes and is clearly 
present in the basal like tumor cells. In contrast, the luminal breast cancer lines MCF-7 and 
T-47D [100], and NSCLC line H358 exhibit much less elongation with tightly packed 
colonization highly favoring cell-to-cell contact. These traits are characteristic of the 
epithelial phenotype and commonly are minimally invasive. All cell types and diameters 
are summarized in Table 4.1.
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Table 4.1: Summary of cell types analyzed in the study. Diameter and surface area 
calculations are reported as mean ± s.e.m. 
Cell Type Description Diameter (µm) Surface Area (µm
2
) 
MDA-MB-231 mammary adenocarcinoma  11.5 ± 0.3 415 ± 19 
MCF-7 mammary adenocarcinoma 17.1 ± 0.4 922 ± 43 
T-47D mammary ductal carcinoma 14.5 ± 0.3 663 ± 34 
A549 alveolar adenocarcinoma 15.0 ± 0.4 710 ± 38 
H358 bronchioalveolar carcinoma 16.8 ± 0.5 890 ± 47 
Peripheral 
Lymphocytes Healthy PBMC 6.7 ± 0.1 142 ± 1 
Peripheral 
Monocytes Healthy PBMC 7.9 ± 0.1 197 ± 2 
Peripheral 
Granulocytes Healthy PBMC 8.2 ± 0.1 209 ± 1 
 
Cell diameters for each cell line were obtained using a Cellometer automated counter 
(Nexcelom). Using regression analysis of cell line diameters with mean forward scatter in 
flow cytometry, the size of PBMC cells were estimated. For all cells a spherical model was 
assumed for surface area calculation. 
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Figure 4.1: Representative bright field micrograph images of cultured breast cancer lines 
(MDA-MB-231, MCF-7, T-47D) and non-small cell lung cancer lines (A549, 
H358). 
4.3.2 Flow cytometric analysis of surface markers 
 Quantitation of surface markers was done using QuantiBRITE PE beads with a SA-
PE conjugate that served as a fluorescent reporter molecule for antigen expression. The 
indirect labeling method used here has minor amplification inherent within. Parallel 
comparison of direct staining with a biotinylated anti-EpCAM and a biotinylated anti-
mouse secondary, both followed with SA-PE staining resulted in a 1.3-fold amplification 
of the secondary staining method shown in Figure 4.2. Although this amplification may 
overestimate the real number of target surface markers, secondary staining was performed 
to remain consistent with traditional immunolabeling in applications of CTC isolation. In 
these rare cell isolation strategies, amplification of labeling is often desired to further 
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separate positive from negative events. Consistent tagging was used for all markers on all 
cell lines to preserve relative expression levels. 
 
Figure 4.2: Phycoerythrin labeling per cell comparison for indirect staining conditions on 
viable A549 cells. Labeling conditions before streptavidin-phycoerythrin 
incubation were (left) covalently biotinylated mouse anti-human EpCAM and 
(right) mouse anti-human EpCAM + biotinylated goat anti-mouse. 
 Expression levels of the quantified markers varied drastically among the studied 
lines and is reported as fold over isotype controls showing expression over non-specific 
binding, as well as normalized against surface area for number of PE molecules per µm2 
on each cell type. These data are presented in Figures 4.3 and 4.4, respectively. Notably, 
the two lines possessing the more invasive morphologies, MB-MDA-231 and A549, are 
also the two that showed lower expression of EpCAM and E-Cadherin than the other three 
lines exhibiting more epithelial morphologies (p < 0.001, Figure 4.4). All statistical values 
are reported in Table 4.2 at the end of this chapter. MD-MBA-231 cells also showed higher 
expression of CD 44, EGFR and ICAM1 over MCF-7, T-47D, and H358 cell lines (p < 
0.01). CD 44 was also expressed at significantly higher levels in A549 cells over MCF-7, 
Biotinylated Primary Primary + Biotinylated Secondary
0
10000
20000
30000
40000
50000
60000
 
# 
Ph
yc
oe
ry
th
rin
 p
er
 C
el
l
45 
 
T-47D and H358 lines (p < 0.01). Integrin αVβ3 has an order of magnitude greater 
expression level for MB-MDA-231 than the other lines examined, registering ~30 PE 
molecules/µm2 (p <0.001). EGFR and ICAM1 showed relatively high expression, at least 
100 PE molecules/µm2, for all lines except MCF-7. These two markers are involved in 
many mechanisms that promote metastasis such as cell migration through the ECM and 
angiogenesis. Their increased expression has been linked to poorer prognoses [96, 101]. 
For breast cancer in particular ERa, PR and HER2 are markers used for subclassification 
of cancer as well as therapeutic targeting. All three breast cancer lines showed a slight 
increase in ERα expression over isotype controls (p-values< 0.05, Figure 4.3 A-C), and 
elevation in expression over NSCLC lines (p-values < 0.05) which showed virtually no 
ERα expression, with the exception of MCF-7 compared to A549 (p=0.15, Figure 4.4 D, 
E). HER2, however had relatively high expression in all lines of 50-100 PE molecules/µm2. 
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Figure 4.3: Summary of tumor marker expression on viable cells. Presented as fold over 
isotype controls for cancer lines and healthy peripheral blood mononuclear 
cells (PBMC) as quantified by flow cytometry analysis of a phycoerythrin 
reporter label. 
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Figure 4.4: Summary of Phycoerythrin labeling density (# PE molecules/µm2 of cell 
surface) for various tumor marker targeting conditions on viable cancer line 
cells and healthy PBMC. 
 For CTC isolation from peripheral blood, target markers must be chosen such that 
CTCs show clear distinction from PBMCs. Targeting markers that are highly expressed in 
both cell types effectively eliminates the ability to distinguish target cells within the 
population. Nucleated blood cells were fluorescently analyzed by flow cytometry with 
gating for the subtypes of leukocytes, monocytes, and granulocytes. Marker quantitation 
for each PBMC subtype was reported as fold over IgG (Figure 4.3F), and then as PE 
molecules/µm2 after normalization to the size of each subtype (Figure 4.4F). These 
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estimates were in fair agreement with the literature [102, 103]. Relatively high staining is 
observed on PBMCs, especially with monocytes, which is somewhat expected due to their 
tendency for nonspecific binding. For further analysis, we report marker expression for 
each cell line over staining for monocytes specifically (Figure 4.5). CD 44 consistently 
showed high expression levels for all cancer cells studied, however would not be 
considered a suitable target due to high non-specific staining observed of CD 44 in PBMCs. 
Targeting CD 44 would likely result in a high occurrence of false positive events. The 
greatly attenuated expression of EpCAM for the more morphologically invasive lines of 
A549 and MB-MDA-231 would also likely produce false positives as a potential target.  
 
Figure 4.5: Summary of phycoerythrin labeling density of all cancer lines studied 
presented as fold expression over healthy monocytes from a peripheral blood 
sample. 
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4.4 Discussion 
 Here we have reported expression levels of commonly studied metastatic associated 
cancer biomarkers through antibody recognition for two breast cancer and three NSCLC 
lines in comparison to PBMC. In the literature, very little quantitative information has been 
reported for surface markers available for viable cell binding. While quantitative assays 
may provide prognostic or therapeutic information with positive/negative reporting, they 
may not be adequate for portraying highly dynamic surface expression of many tumor cells 
for isolation targeting [104-106]. For viable tumor cells the isolation ability is critically 
dependent on the unique surface expression of target cells over other cells within the 
heterogenous population. We propose these results as a significant step toward highly 
effective isolation strategies through informed target marker selection in the isolation 
community. 
 Our results show breast cancer marker expression consistent with the basal or 
luminal characteristics of each subtype. Basal subtypes are often more invasive and show 
less cell-to-cell contact than luminal cancers which are more epithelial-like [100, 107]. The 
basal-like MDA-MB-231 showed elevated levels of metastatic/mesenchymal associated 
markers CD44, N-cadherin, αV-β3 integrin, ICAM-1, as well as upregulation of EGFR as 
is common in basal-like tumors (Figure 4.3A) [107]. These cells also showed less 
expression of the epithelial markers EpCAM and E-Cadherin compared to the luminal T-
47D and MCF-7 lines. Elevation of these mesenchymal markers are indicative of the more 
metastatic cancers as they play key roles in migration, invasion and angiogenesis [108]. 
Invasive cells of this nature are problematic for current isolation strategies that largely 
favor the EpCAM+ cells. Highly invasive cells of this nature are more prone to go 
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undetected in isolation methods due to epithelial marker expression lower than determined 
threshold. 
An interesting result was seen for ERα expression in comparing the basal and 
luminal subtypes. MDA-MB-231 cells expressed similar surface densities of ERα 
compared to MCF-7 and T-47D. Since this study aimed to determine antigen surface 
densities on intact viable cells, differing results may arise from the incorporation of 
intracellular expression levels in literature. The antibody chosen for ERα targeting (clone 
F-10, Santa Cruz Biotech) targeted the C-terminal ligand binding domain and although 
these receptors show presence in the plasma membrane, they are largely a nuclear receptor 
[109]. While intracellular incorporation may be relevant in some applications, it holds no 
benefit for isolation strategies based on surface binding. 
This study offers insight into the expression levels of several metastatic associated 
biomarkers including CD 44, N-Caderhin, ICAM1 and integrin αVβ3 as potential target 
markers [91, 96, 110]. Poorly expressed surface markers clearly serve little utility in 
functional isolation, along with markers that share high expression with that of PBMC 
cells. We found that both N-cadherin and integrin αVβ3 were upregulated on MDA-MB-
231 and A549 lines. However, their utility as potential markers was diminished by the fact 
that expression density was still approximately equal to or below that found on peripheral 
monocytes (Figures 4.4F and 4.5). Additionally, CD44 was consistently high for all cancer 
lines (Figure 4.5) as well as PBMCs. All cancer lines showed expression of a factor of 
nearly 1 or below that found on monocytes except MDA-MB-231 that retained a seven-
fold increase over monocytes (Figure 4.5). Because these markers show expression similar 
to that of peripheral monocytes, they likely would serve poor targets to distinguish CTCs. 
51 
 
Further study may be warranted for the expression of N-Cadherin due to the phenomenon 
known as the ‘cadherin switch’ in which E-Cadherin expression is downregulated while 
N-Cadherin is upregulated is observed in vivo upon cytokine stimulation [88, 111, 112]. 
This increased N-Cadherin expression is correlated with more invasive phenotypes and 
could potentially allow N-Cadherin to serve as a possible target. Our results indicate 
ICAM1 as a potential target for isolation of CTCs. ICAM1 is a cell adhesion molecule that 
plays a significant role in migration, and has been recently been classified as a 
mesenchymal cell marker [113-115]. A recent study has shown that increased populations 
of ICAM1 upregulated CTCs correlated to poorer prognosis [96], further suggesting the 
potential utility of it as a target. 
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Figure 4.6: Summary of phycoerythrin labeling per cell for all markers and cell types. 
Error bars represent the standard error of events collected by flow cytometry. 
In conclusion, we have reported the surface expression of common cancer 
associated biomarkers on three breast cancer and two NSCLC tumor model cell lines. This 
information is critical in any antigen-based method for functional CTC isolation. 
Expression levels observed in this study shed some light on a key reason for poor 
performance in many isolation studies. These results also show the drastic variability in 
marker expression within cancer subtypes illustrating the need for a more dynamic 
approach to CTC isolation as opposed to one target epithelial marker. The intense 
variability shown in Figure 4.6 for cell events within each replicate in the staining protocol 
further supports the shortcomings in isolation methods based primarily on the expression 
of a single epithelial marker. This is likely due to the inherent variability within the cultured 
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cells, as well as the deviations from a mean affinity for each antibody used. Any antibody 
based-assay should carefully consider the variation in antibody affinity across suppliers 
when designing and interpreting methodologies and collected data. Further, heterogeneity 
in marker expression increases even more as some tumor cells undergo the phenotypic 
change known as the epithelial to mesenchymal transition (EMT) [72]. These invasive 
subsets are among the most dangerous and the most difficult to detect due to the lack of 
EpCAM expression. One possible approach to the highly varied surface expression is to 
use a mixture of antibodies to target multiple characteristic surface markers. For example, 
Yu et al. developed a method to target patient-derived breast cancer CTCs with a cocktail 
of EpCAM, EGFR, and HER2 antibodies on an affinity based microchip platform [104].  
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Table 4.2: Summary of student t-test calculations for surface marker data. 
 
 
Line 1 Line 2 Marker Data Type P-value Line 1 Line 2 Marker Data Type P-value
MDA-MB-231 MCF-7 CD44 Label Density 0.0017 MDA-MB-231 monocyte EpCAM Label Density 3.80E-03
MDA-MB-231 T-47D CD44 Label Density 0.0016 MDA-MB-231 monocyte E-cadherin Label Density 8.97E-01
MDA-MB-231 H358 CD44 Label Density 0.0016 MDA-MB-231 monocyte EGFR Label Density 7.40E-03
MDA-MB-231 MCF-7 N-cadherin Label Density 0.588 A549 monocyte EGFR Label Density 1.81E-05
MDA-MB-231 T-47D N-cadherin Label Density 0.8 H358 monocyte EGFR Label Density 1.80E-08
MDA-MB-231 H358 N-cadherin Label Density 0.34 MDA-MB-231 monocyte CD44 Label Density 1.80E-03
MDA-MB-231 MCF-7 ICAM-1 Label Density 0.002 MCF-7 monocyte CD44 Label Density 9.68E-04
MDA-MB-231 T-47D ICAM-1 Label Density 0.0059 T-47D monocyte CD44 Label Density 1.00E-03
MDA-MB-231 H358 ICAM-1 Label Density 0.0022 H358 monocyte CD44 Label Density 1.30E-03
MDA-MB-231 MCF-7 EpCAM Label Density 5.80E-07 A549 monocyte CD44 Label Density 2.00E-03
MDA-MB-231 T-47D EpCAM Label Density 3.57E-05 MDA-MB-231 monocyte ICAM-1 Label Density 2.00E-03
MDA-MB-231 H358 EpCAM Label Density 7.27E-08 MCF-7 monocyte ICAM-1 Label Density 3.41E-02
MDA-MB-231 MCF-7 E-cadherin Label Density 2.20E-04 T-47D monocyte ICAM-1 Label Density 2.44E-04
MDA-MB-231 T-47D E-cadherin Label Density 1.17E-05 H358 monocyte ICAM-1 Label Density 1.05E-05
MDA-MB-231 H358 E-cadherin Label Density 3.99E-06 A549 monocyte ICAM-1 Label Density 4.45E-05
MDA-MB-231 MCF-7 EGFR Label Density 7.50E-03 MDA-MB-231 monocyte aV-b3 integrin Label Density 2.70E-05
MDA-MB-231 T-47D EGFR Label Density 8.40E-03 MCF-7 monocyte aV-b3 integrin Label Density 3.00E-03
MDA-MB-231 H358 EGFR Label Density 1.00E-02 T-47D monocyte aV-b3 integrin Label Density 9.76E-04
A549 MCF-7 CD44 Label Density 9.20E-04 H358 monocyte aV-b3 integrin Label Density 3.00E-03
A549 T-47D CD44 Label Density 9.70E-04 A549 monocyte aV-b3 integrin Label Density 7.20E-01
A549 H358 CD44 Label Density 1.10E-03 MDA-MB-231 monocyte N-cadherin Label Density 2.40E-01
A549 MCF-7 EpCAM Label Density 1.07E-04 MCF-7 monocyte N-cadherin Label Density 9.30E-02
A549 T-47D EpCAM Label Density 1.60E-04 T-47D monocyte N-cadherin Label Density 2.00E-01
A549 H358 EpCAM Label Density 4.27E-05 H358 monocyte N-cadherin Label Density 6.50E-02
A549 MCF-7 E-cadherin Label Density 1.23E-05 A549 monocyte N-cadherin Label Density 7.40E-02
A549 T-47D E-cadherin Label Density 4.80E-08 MDA-MB-231 A549 EpCAM Label Density 6.40E-03
A549 H358 E-cadherin Label Density 3.20E-06 MDA-MB-231 A549 EGFR Label Density 1.40E-02
MDA-MB-231 MCF-7 aV-b3 integrin Label Density 4.15E-05 MDA-MB-231 A549 CD44 Label Density 1.90E-03
MDA-MB-231 T-47D aV-b3 integrin Label Density 3.74E-06 MDA-MB-231 A549 E-cadherin Label Density 1.40E-03
MDA-MB-231 H358 aV-b3 integrin Label Density 5.60E-05 MDA-MB-231 A549 HER2 Label Density 8.20E-04
MDA-MB-231 lymphocyte aV-b3 integrin Label Density 2.30E-04 MDA-MB-231 A549 N-cadherin Label Density 4.48E-01
MDA-MB-231 monocyte aV-b3 integrin Label Density 2.70E-05 MDA-MB-231 A549 aV-b3 integrin Label Density 8.80E-02
MDA-MB-231 granulocyte aV-b3 integrin Label Density 2.80E-04 MDA-MB-231 A549 ICAM-1 Label Density 2.00E-03
MDA-MB-231 isotype ER-alpha Expression 3.80E-02 MDA-MB-231 A549 ER-alpha Label Density 4.30E-02
MDA-MB-231 isotype HER2 Expression 4.15E-04 MDA-MB-231 MCF-7 ER-alpha Label Density 1.10E-01
MCF-7 isotype ER-alpha Expression 1.30E-02 MDA-MB-231 T-47D ER-alpha Label Density 5.00E-03
MCF-7 isotype HER2 Expression 7.50E-04 MCF-7 T-47D ER-alpha Label Density 1.50E-02
T-47D isotype ER-alpha Expression 5.50E-03 MDA-MB-231 MCF-7 HER2 Label Density 7.77E-04
T-47D isotype HER2 Expression 2.70E-03 MDA-MB-231 T-47D HER2 Label Density 1.60E-02
lymphocyte isotype CD44 Expression 1.53E-05 MCF-7 T-47D HER2 Label Density 6.80E-03
lymphocyte isotype ICAM-1 Expression 2.05E-04 MDA-MB-231 A549 ER-alpha Expression 0.05
monocyte isotype CD44 Expression 3.76E-04 MDA-MB-231 H358 ER-alpha Expression 0.047
monocyte isotype ICAM-1 Expression 4.82E-04 MCF-7 A549 ER-alpha Expression 0.15
granulocyte isotype CD44 Expression 7.66E-05 MCF-7 H358 ER-alpha Expression 0.016
granulocyte isotype ICAM-1 Expression 1.33E-07 T-47D A549 ER-alpha Expression 0.007
T-47D H358 ER-alpha Expression 0.0066
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CHAPTER 5. COMMERCIALIZATION OF ASL THROUGH THE USE OF FITC FOR 
PHOTOINITIATION 
5.1 Introduction 
 Eosin Y is among the most common visible light initiators for radical 
polymerization in aqueous media [38, 41, 44, 116, 117]. It has been widely used in the 
formation of cell laden gel due to its ability to generate radical species with low intensity 
visible light while showing minimal cytotoxicity [118]. Visible light photopolymerization 
eliminates the possibility of UV mediated damage when dealing with live cells [37]. Eosin 
Y is a xanthene derivative photosensitizer that is excited by absorption of light at 530 nm. 
Radical generation is achieved through excitation of the eosin molecule where it undergoes 
an intersystem crossing to yield a triplet excited state. In the presence of a tertiary amine 
coinitiator, commonly triethanol amine (TEA), electron transfer from the amine to the 
eosin molecule followed by hydrogen abstraction by eosin yields two neutral radical 
species [40]. Of these two, the TEA radical is much more reactive toward the acrylate 
functional groups [38, 41] that are commonly used in biologically compatible hydrogel 
formation. While the TEA radical initiates chain propagation, a neutral eosin molecule is 
regenerated through a disproportionation reaction where once back in the ground state, can 
again undergo excitation to form more radicals. The cyclic regeneration of eosin makes it 
highly valuable in systems that contain radical quenching species, or limited initiator 
present. It has been shown to generate hydrogel polymerization in systems containing 
1000-fold greater inhibitor concentration over initiator [119]. Eosin has also commonly 
been functionalized to surfaces for generation of thin hydrogel films on cellular surfaces 
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[44], as well as protein conjugation on micro arrays for highly sensitive biodetection of 
ultra-low analyte density [66, 120-123]. Figure 5.1 below shows the polymerization 
reaction scheme with cyclic regenerating photoinitiators. 
 
Figure 5.1: Reaction schematic of A) radical polymerization and regeneration of 
photoinitiator (I = eosin Y or fluorescein), and B) initiator ability to consume 
inhibiting species and regenerate. 
 Our lab has developed a method of surface polymerization that utilizes eosin 
functionalized cells for nano thin film generation [33]. This technology has applications in 
rare cell isolation [33], immunoprotection [124], and is being studied for mechanical 
protection against shear forces in 3D bioprinting. Many cell encapsulation strategies use 
aqueous cell suspensions with eosin in solution to form cell laden bulk gels [118], or 
microscale coatings [116, 125]. Our lab uses cell membrane proteins as targets to highly 
specifically functionalize cellular surfaces with eosin through antibody recognition [33]. 
When suspended in a monomer solution containing TEA and irradiated, localized 
polymerization occurs only near the membrane of initiator labeled cells. This process yields 
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individually encapsulated cells in an ~100 nm thick hydrogel film while retaining high cell 
viability [33]. A limitation in this technology is the lack of commercially available eosin 
conjugates to common biorecognition molecules. Currently researchers must prepare their 
own eosin conjugates to achieve cell surface immobilization [66]. 
 Fluorescein is another molecule that is part of the family of xanthene 
photosensitizers [38]. Like eosin, fluorescein can undergo the same photoinitiation 
mechanisms with a tertiary amine coinitiator to generate active radicals [38, 41, 119]. 
Figure 5.2 below shows the structural similarities between eosin and fluorescein. 
 
Figure 5.2: Chemical structures of eosin Y and fluorescein. 
While eosin has been extensively studied in radical polymerization [38, 40, 116, 119, 125-
129], fluorescein has generally shown comparative results [119, 130]. While fluorescein 
possesses similar abilities of cyclic regeneration for continued radical production, it has 
been shown to be less effective at achieving gelation and also has lower sensitivity 
requiring a greater presence or surface density than that of eosin [119, 130]. 
 In this study we seek to directly compare the ability of fluorescein and eosin to generate 
thin films. Although eosin and fluorescein have been studied simultaneously on polymerization 
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ability [38, 119, 130], the eosin-5-isothiocyantate (EITC) and commercially available fluorescein-
isothiocyante (FITC) have not been evaluated under the cytocompatible conditions of aqueous 
media at neutral pH with decreased coinitiator concentration. We first compare film generation of 
FITC and EITC on protein printed micro array slides which serve as a model for the cell surface. 
Serial dilutions of printed protein afford sensitivity determinations and film thickness analysis 
across a range of initiator surface densities. These micro array slides also offer great reproducibility 
that is not readily observed on living biological substrates. We then compare these initiators on 
living substrates. Epidermal growth factor receptor (EGFR) was targeted on the surface of A549 
cells for initiator immobilization and subsequent hydrogel encapsulation. Hydrogel encapsulation 
was determined by hypotonically challenging the coated populations. Complete hydrogel coatings 
of sufficient thickness provide membrane reinforcement against swelling and lysis in hypotonic 
conditions. We show that FITC is capable of generating films similar to that of ETIC on both micro 
arrays and living cells. As FITC is >10-fold cheaper than EITC by mass and is widely commercially 
conjugated to biorecognition molecules, this work presents an exciting step forward in translating 
our technology to a more standardized process with a range of applications. 
5.2 Chemical structures of eosin Y and fluorescein. 
5.2.1 Micro array printing 
Protein printed micro array slides were prepared as described in Chapter 3.5 with a 
larger range of biotin-BSA (bBSA) concentrations. A total of 24 spots were printed at two 
locations on each slide to be centered in the Whatman Chip Clip well. Two spots of each 
of the twelve bBSA solution concentration were printed on each slide. Serial dilutions of 
1000, 400, 160, 64, 25.6, 10.2, 4.1, 1.64, 0.66, 0.26, 0.1, and 0 µg bBSA/mL were used. 
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5.2.2 Micro array polymerization 
Polymerization on micro array glass slides was done as described in Chapter 
3.6, with minor changes in component concentrations as noted here. Monomer 
formulations contained 420 mM PEGDA-575, 210 mM triethanol amine (TEA) and 
35 mM vinyl pyrrolidinone (VP) in deionized water. Cytocompatible conditions were 
achieved through the use of PBS as a solvent, pH adjustment with 1.2 M hydrochloric 
acid to 7.3-7.5, and lowering the concentration of TEA by 10-fold to 21 mM. Monomer 
solutions were gently bubbled with ultra-pure nitrogen to remove excess oxygen from 
solution. Irradiation was done at 20 or 30 mW/cm2 using a collimated LED lamp 
(M530L3) for 10 min. 
5.2.3 Fluorescent calibration using Cy3 
SA-Cy3 conjugates were labeled on to micro array slides identically to SA-
EITC and SA-FITC as described in Chapter 3.8. Micro array scans for fluorescence 
were done using an Affymetrix 428 array scanner. Fluorescent intensities were 
obtained with excitation from 532 nm laser line and detection with a 570 nm centered 
band pass filter. Fluorophore surface density was determined using a Cy3 calibration 
slide (Full Moon Biosystems). This calibration slide contained highly accurate Cy3 
surface density for 28 values at 2-fold dilution with 12 replicates of each. Using the same 
scanning conditions, a calibration curve was generated and used to calculate surface 
density of bound SA-Cy3 conjugates. 
5.2.4 Surface polymerization of A549 cells 
Cells were cultured and harvested as described in Chapter 3.2. Immunolabeling of A549 
cells was done using a biotinylated mouse anti-human EGFR primary antibody at a 
60 
 
1:100 dilution in blocking buffer of PBS supplemented with 3% fetal bovine serum (FBS). 
200 µL of primary antibody were incubated with 1.5 million cells for 40 min on ice. Cells 
were then washed 2x with blocking buffer. Cells were then labeled with SA-EITC as 
described in Chapter 3.8. Monomer formulations for use with cells contained PEGDA 3400 
(synthesized as reported [33]) for increased cytocompatibility over that of PEGDA 575 as 
generally higher molecular weight PEGDA monomers show decreased cytotoxicity [131]. 
PEGDA 3400 was used at 25 wt/v% with 21 mM TEA, 35 mM VP in PBS with final pH 
adjusted to 7.3-7.5. Monomer solution was bubbled with humidified ultra-pure nitrogen for 
10 min prior to use to remove excess dissolved oxygen. Initiator labeled cells were 
polymerized as described in Chapter 3.9. Briefly, cells were suspended in 350 µL of 
monomer solution and placed into the well of a Whatman chip clip containing a standard 
microscope slide. The chip clip was placed into a polymerization chamber fabricated from 
two polystyrene petri dishes. The chamber was purged with nitrogen for 5 mins before, and 
for 10 mins during irradiation. The sample was irradiated at 30 mW/cm2 for 10 min. Cells 
were then collected and washed 2x in PBS for further analysis. 
 Cell polymerizations using FITC as a photoinitiator were initially labeled with a 
primary antibody as described above. Cells were then labeled with a commercially 
available, FITC conjugated, horse anti-mouse secondary antibody (Vector Labs). 
Incubation of cells in 200 µL of the FITC secondary antibody at a 1:100 dilution was done 
on ice for 40 mins. Cells were then washed in PBS and polymerized as described above for 
EITC labeled cells. 
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5.3 Results and Discussion 
5.3.1 Spectral Analysis of EITC and FITC 
For experimental consistency, one lamp centered at ~530 nm was used for all 
polymerization experiments that has previously been shown to be effective with eosin [19, 
33, 124, 132]. There are a number of xanthene dye derivatives that have been shown to 
absorb light in the visible range. Many of these molecules can also undergo similar 
mechanisms of radical generation in the presence of a tertiary amine. The absorbance and 
intersystem crossing quantum yield of a molecule is highly dependent on the substitution 
of the molecule, which gives rise to a range of fluorescent dyes [38]. This is evident in 
comparing the maximum absorbance of eosin (~530 nm) and fluorescein (~495 nm).  
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Figure 5.3: Analysis of photoinitatior absorbance spectral overlap for (a) SA-FITC and 
(b) SA-EITC with a Thorlabs collimated LED emitting green light. Lamp 
spectra obtained from manufacturer. 
Due to the difference in the maximum absorbance wavelength of these two initiators, we 
first quantify the spectral overlap of the lap with each dye. Extinction coefficients were 
calculated using Beer-Lambert law with absorbance data collected by a UV/Vis 
spectrophotometer (Nano Drop 2000). Normalized emission data from the LED and 
extinction coefficients are plotted in Figure 5.3, and spectral overlap was quantified using 
numerical integration. Extinction coefficients of EITC and FITC agree with literature 
values for eosin Y and fluorescein alone indicating that conjugation to biomolecules have 
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little effect on their spectral properties. Integration reveals the relative amount of light 
absorbed by each species assuming identical concentration. Calculated values show that 
EITC absorbs ~48% more optical energy than FITC. This is not surprising considering the 
maximum absorbance of EITC is almost directly in alignment with the maximum emission 
of the lamp. The absorbance curve of FITC is shifted toward the shorter wavelengths as 
compared to the lamp emission. Absorbance is not the only factor involved in radical 
generation. Triplet quantum yield, as well as regeneration rate are both very important 
factors that greatly affect the gelation rate of the polymer system [38, 119, 130]. However, 
the spectral mismatch of FITC compared to EITC with the chosen lamp presents an 
inherent skew towards the performance of the EITC system.  
5.3.2 Polymerization with micro arrays 
Micro array polymerization allowed us to compare the film generating ability of 
the two initiators in a highly controlled environment that mimics the cellular surface. 
Both non-cell friendly microassay and cell compatible polymerization conditions were 
studied on a range of initiator loading densities. The high binding affinity of the biotin/
streptavidin system [133] allowed us to confidently control the initiator loading by 
varying the biotin concentration within the printed solutions.  
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Figure 5.4: Specific polymerization of photoinitiator tagged micro arrays. (A) Grayscale 
fluorescence scanner image of SA-EITC bound to biotin-BSA printed micro 
arrays. Scan at 50 dB gain with 532 nm excitation and 551/25 nm detection 
with bandpass filter. (B) Grayscale fluorescence scanner image of SA-FITC 
bound to biotin-BSA printed micro arrays. Scan at 50 dB gain with 532 nm 
excitation and 551/25 nm detection with bandpass filter. (C) Bright field 
optical microscopy example image of a micro array sample tagged with SA-
FITC after photopolymerization at 30 mW/cm2 for 10 minutes. 
Local gelation and varying of specific binding to only bBSA printed areas can be seen in 
Figure 5.4. The variation in biotin print concentration is observed for both EITC and FITC 
labeling in Figure 5.4a and 5.4b respectively. Figure 5.4c shows local film generation in 
65 
 
conditions that are conducive to high cell viability. Although this polymerization system 
has been used in rare protein detection with highly sensitive gelation [44], parameters have 
been modified to support living cell applications. Solution tonicity, pH, component 
concentrations, irradiation time and intensity, all must be considered when using living cell 
systems. To account for viability, PBS was used as the monomer solvent, pH was adjusted 
to physiological levels (~7.5), and the toxic component of TEA was reduced by 10-fold 
from 210 mM to 21 mM. 
 Thickness of generated film for EITC and FITC under cell friendly conditions 
under two different radiation intensities can be seen in Figure 5.5. Film thickness was 
recorded by profilometry. The highest film generation of ~145 nm average thickness 
occurred with 30 mW/cm2 radiation of SA-EITC functionalized spots at the highest bBSA 
densities.  
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Figure 5.5: Comparative analysis of polymer gelation thickness vs. photoinitiator density 
for SA-FITC and SA-EITC tagged micro array samples. Analysis was 
conducted with cell compatable conditions consisting of 420 mM PEG-
diacrylate, 21 mM triethanol amine, 35 mM vinyl pyrrolidone, in phosphate 
buffered media (pH=7.5) with a constant reaction time of 10 minutes. 
The EITC labeling density for these spots was ~18,000 molecules/µm2, and yielded film 
generation comparable to previously published works with similar conditions [124, 132]. 
Increased radiation intensity generally showed increased film generation as expected for 
both EITC and FITC. Increased radiation likely increases the influx of active radicals for 
faster gelation at similar initiator loading, especially at the higher initiator surface densities. 
While neither initiator showed any appreciable film generation at the lowest print 
concentrations, EITC does show a lower threshold for initial gelation indicating a higher 
sensitivity. Lower threshold limits were ~1,200 molecules/µm2 for EITC and ~1,800 
molecules/µm2 for FITC. 
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 Film generation by FITC initiation was generally lower than EITC for the same 
loading conditions. However, FITC was still able to record appreciative polymer formation 
even with the discussed disadvantage of spectral mismatch. At high initiator loading and 
high intensity, FITC was able to generate films that averaged ~100 nm, which is very 
different than previously reported studies for fluorescein in aqueous conditions [38]. These 
reports have stated that quantum yield of the triplet state and radical generation is much 
lower for fluorescein than that of FITC. However, a large difference in our study is the use 
of the 530 nm LED. Other studies have used sources with a very narrow bandwidth such 
as laser lines that are either well above 500 nm or near 400 nm [130]. As we have calculated 
that FITC absorbs ~48% less light than EITC with our relatively broad bandwidth source, 
absorption would decrease drastically with decreased bandwidth. These studies suggest 
that a light source that is further aligned with the absorption profile of FITC would 
considerably increase absorption and radical generation for initiation of polymerization. 
 This study also evaluated the film generation in ‘unconstrained’ conditions which 
are not conducive to cell viability. Coinitiator concentration was increased 10-fold, pH was 
not adjusted, and the solvent was not buffered. Figure 5.6 shows the drastically increased 
film generation of the FITC initiated unconstrained system. Sensitivity is increased nearly 
2-fold to a threshold of ~1000 molecules/µm2, and film generation rivals that of previously 
reported values for EITC initiated systems.  This suggest the possibility of the 
commercially available FITC bioconjugates for use in sensitive biorecognition assays. 
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Figure 5.6: Comparison of polymer gelation thickness vs. photoinitiator density with cell 
compatible and unconstrained formulations and FITC photoinitiation. All 
samples were irradiated with 20mW/cm2 of green light (530 nm LED lamp, 
ThorLabs) for 10 minutes. Cell compatible = 420 mM PEG-diacrylate, 21 mM 
triethanol amine, 35 mM vinyl pyrrolidone, in phosphate buffered media 
(pH=7.5). Unconstrained= 420 mM PEG-diacrylate, 210 mM triethanol amine, 
35 mM vinyl pyrrolidone in deionized water. 
5.3.3 Cell encapsulation using FITC initiated systems 
For comparison of EITC and FITC on living cell encapsulation, epidermal growth 
factor receptor (EGFR) was targeted on the surface of the non-small cell lung cancer line, 
A549. A549 cells have been shown to overexpress EGFR, which serves as a prototypic 
model for FITC initiation in a live cell system. Cells were first labeled with mouse 
antibodies against human EGFR followed by initiator labeling with either SA-EITC or a 
FITC labeled secondary antibody. Initiator labeling was confirmed by green fluorescence 
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using flow cytometric analysis. Polymerization was carried out with cell friendly 
conditions and viability was assessed by MTT assay shown in Figure 5.7 (figure caption 
on page following figure). Viability following polymerization was maintained for both 
initiating systems. While different cell lines may show different susceptibility to toxins, 
these data show that FITC, like EITC, is generally compatible for surface polymerization 
on living cells. Polymerized cells were then subjected to hypotonic conditions where 
uncoated cells are lysed, while cells possessing a complete coating are protected from the 
harsh conditions [21, 33]. The FITC initiated system shows very comparable results of 
~20% viability following hypotonic challenge.  
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Figure 5.7: Polymerization of A549 cells using an eosin or fluorescein photoinitiator 
targeted to EGFR and PEGDA3500 as a monomer. (a) Fluoroscence image of 
A549 cells coated with red fluorescent hydrogel using an eosin photoinitiator. 
(b) Fluoroscence image of A549 cells coated with red fluorescent hydrogel
using a fluorescein photoinitiator. (c) Viability of A549 cells determined using 
MTT assay at various stages of polymerization (n=3). 
These findings indicate film generation with a commercially obtained FITC 
bioconjugate is similar to that of the SA-EITC that is extensively used. Cell viability data 
and micro array studies agree with the performance of FITC compared to EITC. Our 
results support the use of FITC initiated systems for cellular encapsulation in isolation 
[21, 33], immunoprotection [33, 134-136] applications as well as sensitive 
polymerization-based amplification [44]. 
5.4 Conclusion 
In this study we directly compared the initiating ability of SA-EITC and SA-FITC 
on micro array formats under cytocompatible conditions. We sought to determine the 
feasibility of commercially available FITC conjugates for live cell encapsulation as a 
standardized alternative to custom SA-EITC conjugates. Although spectral calculations 
indicate that FITC absorbs 48% less light than that of EITC for the 530 nm LED used here, 
film generation on micro array systems were comparable. FITC systems were able to 
generate films of ~100 nm in the constrained cell friendly environments and ~350 nm is 
unconstrained conditions. Live cell studies indicated very similar viabilities of polymer 
coated cells as well as hypotonically challenged cells with either system. These results 
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support the use of commercially available FITC-conjugates for single cell encapsulation, 
thus further standardizing the encapsulation process. 
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CHAPTER 6. SCALING PROCESS TO THERAPEUTIC SCALE FOR ACCURATE CTC 
DETECTION AND ISOLATION 
6.1 Introduction 
 Cancer is a leading cause of death in the United States and worldwide. With an 
estimated over 1.7 million new cases in 2017, and a lifetime probability of diagnosis of 
40.8% and 37.5% for men and women respectively, cancer research is among the most 
intensely studied diseases [137].  Tools for early diagnosis, prognosis, and effective 
treatments in this drastically heterogenous disease are rigorously studied [67, 69, 70, 138]. 
A subset of cancers and by far the most lethal, are the metastatic diseases. Metastasis occurs 
when cells from the primary tumor make their way into the blood stream, travel to a distant 
site and exit circulation where they colonize and begin the formation of a secondary tumor 
[24, 26, 67, 71]. Metastatic cancers are responsible for >90% of all cancer related deaths 
[26, 67]. Multiple mechanisms are thought to be responsible for the presence of circulating 
tumor cells (CTCs) including leaky vasculature, and a phenotypic change from more 
adhesive cell type to much more invasive and mobile cells called the epithelial to 
mesenchymal transition (EMT) [88, 139]. EMT is thought to be a reversible process where 
cells lose epithelial nature to enter circulation, but then regain lost characteristics during 
colonization at a distant site [139]. Tumor cells in circulation were first observed over 150 
years ago [68], and have been widely studied ever since [24, 26, 67, 71]. Recently, the 
concentration of CTCs in peripheral blood has been shown to provide important prognostic 
information in some cancers [29-31, 140]. Not only does accurate detection of these cells 
serve as a prognostic indicator, but these cells present the possibility of an early diagnostic 
tool in the form of a ‘fluid biopsy’. These CTCs are believed to appear in blood as many 
as 17 years before a primary tumor becomes large enough to detect with typical scans [71]. 
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Early diagnosis of cancers, especially the lethal metastatic variety, would allow patients to 
undergo treatment years before the current timeline which would greatly increase survival 
rates [69, 70]. This diagnostic tool also has the advantage of being minimally invasive as 
opposed to invasive and often painful solid tumor biopsies. Accurate detection and 
enumeration of CTCs is plagued by the extreme rarity at which they occur (~1 CTC per 
million nucleated blood cells), and the vast heterogeneity in characteristic marker 
expression between cancers [24], as well as a result of EMT [26]. The rarity at which CTCs 
are observed in blood indicate the need for a robust detection method that can process large 
cell numbers while maintaining high sensitivity. 
 The two most common types of viable cell isolation techniques are magnetic 
activated cell sorting (MACS) and Fluorescent activated cell sorting (FACS). These two 
methods both use antibodies that target antigen expression characteristic of the target cell 
population to distinguish them from the rest of a heterogenous sample. MACS uses 
antibody functionalized magnetic microbeads to label target cells rendering them 
susceptible to magnetic fields. Cell are then passed through a column that is placed within 
a strong magnetic field. Magnetically functionalized cells are retained at the wall of the 
column while all other cells pass through, followed by removal of the magnetic field and 
collection of target cells. FACS surface functionalizes specific cells with fluorochromes. 
Flow cytometry is then used to physically separate target cells from the rest of the 
population. Using microfluidics to funnel cells into single file, cells are fluorescently 
analyzed one-by-one. The sample stream is aerosolized into microdroplets containing 
individual cells. Each droplet is electrically charged based on the cell’s fluorescent 
characteristics before passing through an electric field where droplets are deflected to 
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separate containers based on charge. While MACS maintains the advantage of high sorting 
speeds (up to 1011 cells in ~30 min) [75], the isolation purity is far less than desired, and is 
dependent on initial target cell population [78, 79]. FACS is able to achieve very high 
purities but is greatly limited by the processing time in large cell numbers due to analysis 
of each individual cell. 
 Currently, the only FDA approved CTC enumeration method for clinical utility is 
the CellSearch system [29-31, 140]. CellSearch uses MACS as a pre-enrichment step 
followed by cell fixation, permeation and intracellular staining for characteristic epithelial 
markers. Stained cells are then analyzed by a Celltracks Analyzer II where positive cells 
are determined visually by the user. While magnetic enrichment decreases the overall cell 
count to be analyzed microfluidically, processing time may still be a challenge when 
scaling batch sizes. The major limitation of the CellSearch system is the lack of viable 
isolated cells. Fixation and intracellular staining may provide prognostic information, but 
at the cost of translation of the technology. Fixation limits the applications of the 
CellSearch system to enumeration only, and provides no possibility of functional cell 
analysis or use of isolated cells. 
 Our lab has developed an isolation strategy that possesses the processing power of 
MACS and the isolation purity of FACS using relatively inexpensive materials. Antigen 
specific lysis (ASL) uses antibody recognition similar to that of MACS and FACS to very 
specifically distinguish target cells within multiple populations. Target cells are surface 
functionalized with a visible light photoinitiator, where upon radiation in the presence of 
monomer will initiate localized polymerization individually encapsulating target cells in a 
protective hydrogel. The entire population is then subject to harsh conditions, such as ionic 
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surfactants, in which all antigen negative cells are lysed while polymer coated cells are 
protected leaving a nearly 100% pure population. A major proposed advantage to this 
technology is the ability to scale batch size by one to two orders of magnitude with little to 
no increase in processing time. Scaling systems that require flow cytometric analyses are 
also accompanied by a directly proportional increase in processing time. A fluid biopsy for 
screening is likely on the order of 10-100 mL of peripheral blood. In an adult, this would 
contain 108-109 peripheral blood mononuclear cells (PBMCs). For FACS to accurately 
process this number of cells would be on the order of 10-20 hours for one sample. ASL has 
the potential to accomplish the same FACS purity in as little as 1 h per sample. Another 
major advantage of ASL is the result of viable cells upon isolation, which allows 
enumeration of CTCs like CellSearch while further adding the aspect of functional CTC 
analysis upon isolation. The clinical utility of a fluid biopsy for early cancer detection, 
prognostic information, and functional analysis of these highly sought-after cells is 
invaluable. 
Here, we systematically study all parameters associated with the ASL processing 
for rare cell isolation for scaling to a clinically relevant batch size for potential fluid biopsy. 
Optics, chamber materials, chamber geometry, cell densities, fluid volumes, and more are 
studied to determine what factors are key to successful rare cell isolation. 
6.2 Materials and Methods 
6.2.1 Micro array printing 
Micro arrays were fabricated as described in Chapter 3.5, as well as additional slides 
with minor changes in printed concentration of bBSA solutions. All spots were printed 
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with the same concentration of bBSA to ensure identical biotin surface densities for 
accurate analysis of other parameters. All array spots were printed with a bBSA 
concentration of 160 µg/mL in PBSA for a total protein concentration of 1000 µg/mL. 
6.2.2 Radiation intensity with increase monomer volume 
Whatman incubation chambers were firmLy held against a standard microscope 
slide using binder clips. Clips were positioned such that slides were able to lay flat upon 
the radiometer detector without any obstruction of optics. Complete PEGDA 700 monomer 
formulation was added to the slide first at 150 µL followed by 100 µL additions. Radiation 
intensity was recorded along with the total monomer volume after each addition. All 
monomer formulations for intensity measurements and polymerization experiments on 
micro arrays used PEGDA 700 as described in Chapter 3.6. 
6.2.3 Maximum Target Cell Density 
Maximum target cell density was assessed by varying number of total cells 
processed with volume processed. Physical parameters such as fluid depth and radiation 
incident angle were controlled by changing only chamber surface area to vary volume. 
Three glass bottom dishes (Cellvis) of varying diameters (10, 14, 20 mm) with constant 
well depth were used. All glass bottom dish diameters were well within the diameter of the 
radiation beam. Polymerization using PEGDA 700 on cell surfaces was performed as 
described in Chapter 3.9. 
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6.3 Results and Discussion 
 Here, we sought to quantitatively assess the parameters associated with localized 
polymerization on both controlled micro array formats as well on living cells. Initiation of 
polymerization through visible light radiation is highly dependent on observed radiation 
intensity by the photoinitiators. This has been shown in multiple studies including the 
previous chapter and is observed in Figure 5.6. When scaling the process, volume of 
monomer solution used, and perhaps more importantly, depth of a monomer within the cell 
solution chamber can have a large effect on the radiation which cells further from the 
solution surface see. The monomer solution is relatively clear and colorless and therefore 
absorption of visible light is minimal, but slight turbidity and light scattering play a role. 
Using a radiometer, we monitored the effect of fluid depth on radiation intensity observed. 
Figure 6.1 shows the normalized radiation intensity with different monomer volumes 
within the polymerization well. 
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Figure 6.1: Normalized observed radiation intensity for increasing volume of monomer 
solution. Values are normalized to observed radiation through a standard 
microscope slide in the absence of monomer solution. 
All values were normalized to the radiation observed in the presence of the glass slide and 
absence of monomer solution. As expected, radiation observed by the detector after passing 
through the solution slightly decreases in intensity. One interesting observation is the 
radiation intensity appears to level off as monomer addition is continued. This may be 
explained partially by the irregular geometry of the chamber wall as fluid depth increases, 
as well as meniscus effects with chamber wall. With these variables, 100 µL additions may 
not directly translate to an increase in fluid depth associated with a perfectly square or 
circular wall geometry. Therefore, additional experimentation is warranted using a more 
controlled geometry. In light of these findings, we proceeded to determine the effect of the 
80 
fluid depth on film generation using micro array slides. Figure 6.2 reports thickness 
of generated film as determine by profilometry for multiple monomer volumes in the 
same size well. 
Figure 6.2: Thickness of generated polymer film determined by contact profilometry for 
multiple monomer volumes within the same chip well. 
From Figure 6.2 it is evident that the volume of solution plays a significant role in the 
ability to generate polymer. However, the drastic decrease in film generation correlated to 
the difference in observed radiation intensity suggests that there are more factors effecting 
the system than fluid depth alone. Figure 6.1 shows less than a 2% difference in observed 
radiation intensity from 350 µL to 550 µL of monomer solution, as Figure 6.2 shows an 
~4-fold decrease in film generation from 350 µL to 550 µL. Another major factor in radical 
polymerization that would depend on solution volume is the presence of oxygen in 
solution. Oxygen is known to quench active radical species hindering free radical 
polymerization. For this reason, all polymerizations are carried out under an inert nitrogen 
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atmosphere. As described in Chapter 3.9, the system is purged for 5 mins before and for 
the duration of irradiation. Purging the system with nitrogen facilitates diffusion of oxygen 
out of solution for less radical quenching. Increasing solution volume affects the rate at 
which oxygen leaves the system. As concentration is the driving force behind mass 
transport, increased fluid depth correlates to increased time before a change in oxygen 
concentration is observed at points furthest from the solution/nitrogen interface. Additional 
experimentation was done using nitrogen bubbled solutions. Identical processing to that of 
data collected for Figure 6.2 was done, with the additional step of gently bubbling nitrogen 
through the solution. Although this step introduces additional variables such as evaporation 
of solvent which may result in slight changes in component concentration, it greatly 
increases the rate at which oxygen is removed from solution. Figure 6.3 shows the 
thickness of generated film for the experiment including nitrogen bubbling. 
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Figure 6.3: Thickness of generated polymer film determined by contact profilometry for 
multiple monomer volumes within the same chip well after nitrogen bubbling 
of the monomer solution. Dashed lines indicate nitrogen bubbled monomer 
studies, while solid lines indicate studies without bubbling nitrogen through the 
monomer before use. 
While there still appears to be a trend in monomer solution depth and with thickness of 
generated film, the distinction is less evident. These data support the hypothesis that 
oxygen diffusion plays a role in film generation through the increase thickness for all 
monomer volumes studied and the increased sensitivity in film generation of 450 µL and 
550 µL volumes on the lower biotin printed spots. Additional experimentation of these 
conditions may be required to allow statistical analysis for this parameter. 
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Next, we looked to determine the film generation dependence on the variation in 
light intensity within the radiated area as well as meniscus effects at the edges of the 
solution chamber. Although the collimated light source is theoretically consistent in 
radiation intensity in the beams cross sectional area, slight variations are inherent within 
the LED system. Additionally, the angle of incidence between light and the solution will 
affect the amount of light transmitted across the change in medium. With the micro array 
centered within the chip clip well, the solution fluid is relatively flat and therefore the angle 
of incident light essentially 0˚, which facilitates a maximum transmittance. In the meniscus 
region however, this angle will be significantly greater. In cellular studies, as opposed to 
micro array polymerization, target cells occupy the solution well and not just the 
center. Figure 6.4 demonstrates how each of these parameters effect film generation. 
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Figure 6.4: Normalized film thickness generated on micro arrays under varying 
conditions. Left: Array centered within the chip well and centered within 
radiation area. Middle: Array positioned at the edge of the chip well where the 
meniscus is most prominent while centered under radiation area. Right: Array 
centered within chip well while positioned at the edge of radiation area where 
variation in light intensity is most prominent. Top: Normalized film generation 
(x and y axes represent printed micro array position analyzed. Conditions 
varied in the x direction). Bottom: Schematic of polymerization set up (View 
of the x-z plane). 
It is evident from Figure 6.4 that the meniscus plays a crucial role in film 
generation on micro array polymerization. Light variation across the collimated source is 
also a minor factor as is evident from the slight decrease in film generation in spots as 
they approach the edge of the beam. It is worth noting that while there is not 
quantitative data for the combined effect of lamp variation and the meniscus it is 
highly likely that the two 
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parameters would compound to show an even greater deficit in film thickness. Again, this 
becomes a more significant issue in cellular polymerizations as a large number of cells 
occupy this area. 
 
Figure 6.5: Analysis of total cells processed with total volume processed. Lines draw 
estimated distinction between observed bulk gelation and individual cell 
encapsulation. 
In conjunction with acellular studies, cellular experiments were also conducted. As 
maximum target cell density is not likely an issue regarding rare cell isolation, we still 
explore this parameter for rigor as exceeding this maximum results in bulk gelation of the 
sample in a covalently crosslinked system. As shown in Figure 6.5, we have observed an 
upper limit of target cell density to be ~6-8 million cells/mL. At this point small bits of 
bulk polymer will form in solution. Exceeding these cell densities resulted in nearly a one 
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continuous crosslinked network of cell laden hydrogel. Minimum target cell density is 
among the most important of the parameters as CTCs are on the order of 1 per million 
PBMCs. Achieving this level of sensitivity is crucial to providing diagnostic and prognostic 
information in a clinical setting. 
6.4 Conclusion 
 Here we systematically study the processing parameters of ASL for scaling to 
clinically relevant batch sizes. This system has the potential to provide highly sensitive, 
viable cell isolation for the application of CTC detection in a fluid biopsy. As the only FDA 
approved method for CTC enumeration does not produce viable cells for functional 
analysis, we propose a novel and scalable alternative to viable cell isolation in ASL. 
Through the information gained in this study, we can improve the efficacy of the current 
batch sizes as well as determine what parameters are of great importance in clinically 
relevant batches. Although experimentation is ongoing, we have learned a great deal in 
acellular studies. Angle of incident light, and monomer solution depth (with roles of 
oxygen diffusion) appear to have great effects on the ability to generate film on micro array 
slides. These data suggest that increasing processed volumes by increased solution 
chamber surface area as opposed to depth would be beneficial. This would minimize 
attenuation of light by scattering within the monomer solution as well as allow for rapid 
diffusion of oxygen away from the system. A potential problem is that increased surface 
area also increases evaporation rate of monomer solution in volume per time. Additionally, 
solution chambers that have a minimized meniscus, maximizing light at a normal incidence 
would also maximize the efficiency of the irradiated area. 
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CHAPTER 7. MECHANICAL PROTECTION FOR HIGH RESOLUTION, HIGH THROUGHPUT 3D 
CELL PRINTING 
7.1 Introduction 
 The shortage of donor organs continues to be critical problem [141]. Efforts have 
been made through education programs and expanded donor criteria to increase the number 
of donors [142], but the demand continues to rise faster than supply. Every day 20 patients 
die waiting on a donor organ (based on OPTN data for 2017). There are currently over 
4,000 patients on the waiting list of a heart while less than 3,300 heart transplants were 
conducted in the entire year of 2017 (based on OPTN data for 2017). The drastic deficit of 
cadaverous and live organ donors to the demand clearly highlights the need for a new 
source of viable organs. 3D bioprinting shows great promise in bridging this gap between 
supply and demand. 3D bioprinting is the precise deposition of biological or biocompatible 
components into constructs to imitate or replicate natural functions. Non-biological 3D 
printing has gained great momentum in the past two to three decades. It has been used to 
print a range of structures from toys and trinkets, to objects for educational purposes, to 
functional prosthetics [57, 58]. 3D printing has proved to be very useful for education in 
the medical field [143]. Printed anatomical structures help to visualize the complex 
morphologies in ways that 2D representations fail. This can be especially important in 
surgical planning where imaging and printing surgical sites of interest or anomalies can 
greatly prepare surgeons for medical procedure [46, 47]. In recent years, this technology 
has been translated to use with biocompatible materials in printing numerous cellular and 
acellular structures for tissue engineering in regenerative medicine [48-54], and 3D organ-
on-a-chip for in vitro drug screening [55, 56]. The world of 3D bioprinting holds an 
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exciting future in a range of biological applications including the printing of whole organs 
for transplant. 
 The keys to successful tissue/organ printing are precise, high throughput deposition 
of viable cells. Incorporation of vasculature within large tissue is critical for transport of 
nutrients to sustain viability, but requires extremely high-resolution printing. With the 
harvesting, propagation, and differentiation of a patient’s own stem cells, tissues can be 
printed with the necessary numbers and phenotypes while ensuring that the possibility of 
graft vs. host rejection is nearly eliminated [48, 53, 144]. This type of transplant is 
essentially an autograft. 3D bioprinting has made great strides in the past 5-10 years, but 
there are still many challenges that must be overcome before viable organ printing is 
achieved. 
 Extrusion based bioprinters are a common type of printer that are commercially 
available. These printers use pressure or mechanically driven flow to extrude material 
through a small nozzle for direct write printing [59]. These types of printers are common 
due to their simple design, moderate affordability, and compatibility with a large range of 
viscosity bioinks and cell densities [48, 59, 145]. Some of these printers even have the 
capability of printing multiple cell types through a multi-head printer design [53, 146, 147]. 
When printing cellularized scaffolds, these printers commonly use a suspension of cells in 
a cytocompatible material, or ‘bioink’ for deposition onto a substrate. Common bioinks 
consist of poly-(ethylene glycol) (PEG) acrylates, gelatin, collagen, and alginate [48, 49, 
51, 53, 54, 62, 64, 65]. As advances in tissue engineering continue to be made, the choices 
of biocompatible materials for potential bioink is increasing. 
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Figure 7.1: (Top) Schematic representation of cell deformation due to mechanical forces 
during extrusion printing. As printing resolution increases from left to right 
with constant flow rates, fluid velocity increases along with shear stress, τ, and 
pressure drop, ∆𝑃. (Bottom) Stress/strain relationship for PEGDA 2000 
subjected to uniaxial tension with representation of coated and uncoated cell 
response to increasing fluidic shear.   
 Extrusion based printers carry with them the inherent challenge of shear mediated 
cell damage. While tensile, compressional, and shear forces are all mechanical stimuli a 
cell can experience during the printing process [64, 148, 149], shear forces have been the 
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main concern in maintaining cell viability and membrane integrity [65, 150, 151]. In fluid 
flow through a small pipe, shear forces are created by the radial velocity gradient associated 
with laminar flow [152]. These forces are highly dependent on pipe or capillary diameter 
as well as flow rate. Figure 7.1 shows a schematic for the effect of shear forces on living 
cells. For large tissue/organ printing, the combination of high throughput (high flow rate) 
with high resolution (small capillary diameter) presents a critical issue for reduced cell 
viability from shear-mediated death. 3D cell printing is commonly performed at resolutions 
much greater than that of a single cell (150-300 µm nozzle diameter) and at flow rates that 
are typically on the order of 1-10 µL/min. [60-63] With these current printing conditions it 
would take on the order of 100 days to print one organ without achieving the necessary 
resolution required for small vasculature. In efforts to minimize shear forces experienced 
by cells, studies have been done in areas such as altering print heads [64], using low 
viscosity bioinks [65] or using shear thinning fluids [63]. These printing techniques have 
been able to print with high cell viability, but still with moderate resolution and relatively 
low throughput. Advances must continue to be made in order for whole organ printing to 
be done on a time scale plausible for transplantation. 
 In this study, we analyze the protective potential of hydrogel encapsulation against 
the mechanical forces of high throughput, high resolution cell printing. Through a novel 
encapsulation method developed in our lab, we examine polymers possessing a range of 
mechanical properties on their ability to reinforce the cell membrane during extrusion. Rat 
cardiac myoblasts (H9C2 cell line) were used as a model for cardiac tissue printing. These 
cells were individually encapsulated by surface mediated photo-initiated radical 
polymerization [33]. Both uncoated and surface functionalized cells were extruded through 
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50 µm diameter capillary at 4.8 µL/s. Cells were then analyzed for intactness using 
scattering parameters in flow cytometry upon extrusion, as well as using two viability 
assays. We then sought to decouple the cellular damage caused by rapid pressure changes 
and shear associated with high throughput extrusion printing. Each parameter was tested 
separately outside the system of extrusion for individual analysis. Mechanical properties 
of each polymer were recorded for correlation to protection potential. This work aims 
toward providing membrane reinforcement for simultaneous high resolution and high 
throughput bioprinting for goals in whole organ printing.  
7.2 Materials and Methods 
7.2.1 Cell Encapsulation 
Five different monomer formulations were evaluated for their protective potential in a high 
shear, extrusion environment. All formulations contained equal amounts of the co-initiator 
triethanolamine (TEA, Sigma >99%) and co-monomer vinyl pyrrolidinone (VP, Sigma 
>99%) at 35 mM each. PEGDAs 700 (Sigma), 1000, 2000, and 3400 were all used at 25% 
w/v, and the fifth formulation was 1% w/v of PEGDA 3400 with 3% w/v gelatin 
methacryloyl (gelMA; BioBots). The formulation containing gelMA and PEGDA 3400 is 
denoted as gelMA/3400. PEGDA 1000, 2000 and 3400 were all synthesized in house as 
described in Chapter 3.1. All other procedures including cell culture, viability assays, 
extrusion, and analysis are described in Chapter 3. 
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7.3 Results and Discussion 
7.3.1 Mechanical Properties 
Here, we present an extended application to a novel method of individual cell encapsulation 
using surface mediated radical polymerization developed in our lab. Encapsulation in a 
protective hydrogel provides mechanical protection of rat cardiac myoblasts for 
simultaneous high resolution and high throughput bioprinting. We have shown that 
encapsulation in thin hydrogel polymers possessing the right mechanical properties yield 
significantly more intact cells over uncoated cells upon exposure to high shear forces 
experienced traveling at high speeds through a narrow capillary. 
Young’s modulus is a measure of hydrogel stiffness. The Young’s modulus, which is 
commonly referred to as the modulus, of the gel is a measure of the deformation (strain) of 
the gel required to develop a given stress. Stiffer materials have a higher modulus and 
therefore generate a larger stress from the same deformation as softer materials. The 
modulus of each gel was calculated by equation (1) below, 
𝐸 ≡ () = + ,-∆. ./- .      (1) 
Where 𝜎 is the stress, or generated force, F, per cross sectional area, A, and 𝜖 is the strain, 
or change in sample length, DL, relative to initial length, Lo. Moduli ranged from 9.2 +/- 
0.8 kPa for gelMA/3400 to 1269 +/- 103 kPa for PEGDA 1000. Although PEGDA 700 did 
not have the highest average modulus (Table 7.1), the means between PEGDA 1000 and 
PEGDA 700 were not statistically different, suggesting that the small difference in 
molecular weight did not greatly affect the mechanical properties and therefore still 
preserving the expected trend between modulus and monomer molecular weight.  
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Table 7.1: All mechanical properties recorded for each polymer assessed. Data reported 
as mean ± standard deviation. 
Monomer Swelling Ratio Modulus Ultimate Tensile Strength (kPa) 
Max Strain 
(%) 
700 3.02 ± 0.03 1.21 x 103 ± 127 138 ± 36 11 ± 2.7 
1000 3.77 ± 0.12 1.26 x 103 ± 103 128 ± 26 9 ± 1.4 
2000 5.41 ± 0.12 502 ± 61 134 ± 23 9 ± 3.6 
3400 7.21 ± 0.01 204 ± 20 55.0 ± 7.1 25 ± 0.94 
GelMA/3400 15.4 ± 0.89 9.2 ± 0.79 6 x 10-4 ± 3 x 10-4 44 ± 13 
 
The expected trend of increasing modulus with decreasing molecular weight is due to the 
formation of a more tightly crosslinked network. As molecular weight decreases, molecular 
weight between crosslinks also decreases limiting the mobility of polymer chains within 
the gel and therefore increasing the observed stiffness. 
Ultimate tensile strength (UTS) and percent elongation at failure (%EL) were calculated 
by equations (2) and (3) respectively.  
𝑈𝑇𝑆 = +5, .       (2) 
%𝐸𝐿 = ∆𝐿 𝐿8- × 100%.      (3) 
Where, 𝐹= is the force applied at the point of failure. Swelling ratios were determined as 
described by equation (4) below, 
𝑆𝑅 = ?@A?B?B .       (4) 
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Where ms is the mass of the swollen gel and md is the mass of the dried polymer. The 
calculated swelling ratios of the five formulations ranged from 3.02 +/- 0.03 for PEGDA 
700, to 15.41 +/- 0.89 for gelMA/3400. As expected, the swelling ratio decreases as the 
molecular weight of the monomer decreases similarly to that of the modulus. This is due 
to a decrease in molecular weight between covalent crosslinks within the hydrogel network 
limiting the ability of the gel to take on water and swell. 
7.3.2 Protective Potential 
Cell samples were analyzed by flow cytometry both before and after extrusion 
process. Events were gated for intact cells in samples before being extruded through the 
capillary. These same gates were used to determine the fraction of cells that remained intact 
after the harsh forces of high flow rate extrusion through the capillary. Figure 7.2 is a 
representation of how each sample was gated and analyzed.  
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Figure 7.2: Sample gating of flow cytometry scatter plots for PEGDA 2000 coated cells 
before (a) and after (b) extrusion, and uncoated cells before (c) and after (d) 
extrusion. The red circle indicates the gated region consistent with intact cells. 
Upon extrusion through the capillary tube, percentage of intact cells were recorded 
and normalized to the percentage of cells that fell within the gate prior to extrusion. Cells 
were then analyzed by two different viability assays: MTT proliferation assay, and 
ethidium homodimer permeation assay. Figure 7.3 shows all of the scattering and viability 
data compiled for each polymer used.  Asterisks indicate means that are statistically 
different from the uncoated cell populations as determined by Student’s t-test in Matlab. 
P-values for Figure 7.3 are given in Table 7.2. 
96 
 
 
Figure 7.3: Cell viability for each assay type following extrusion for each polymer 
coating. (* indicates statistically different mean than the corresponding 
uncoated group.) 
Table 7.2: P-values generated using Student’s t-test for samples following extrusion when 
compared uncoated cells (Figure 7.3). 
 P-Values 
Polymer Type Scattering 
Analysis 
EthD-1 MTT 
PEGDA 700 0.005 0.003 0.107 
PEGDA 1000 0.039 0.062 0.110 
PEGDA 2000 0.027 0.179 0.165 
PEGDA 3400 0.462 0.050 0.173 
GelMA/3400 0.924 0.980 0.945 
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These viability data were then plotted against the measured mechanical properties of each 
polymer to observe trends in protection potential. Figure 7.4 shows each polymer property 
plotted against ethidium permeability assay as well as fraction intact as determined by 
scattering properties in flow cytometry. MTT assay viability was left out of these figures 
for clarity. 
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Figure 7.4: Mechanical properties of each gel plotted against ethidium permeability assay 
and scattering properties. (a) swelling ratios, (b) modulus, (c) ultimate tinsel 
strength, (d) percent elongation at failure. Polymer legend, scattering data, and 
ethidium assay data are vertically in line with one another for a specific 
polymer. 
From this figure it can be observed that there is a clear trend between percentage of intact 
cells by scattering to swelling ratio and modulus. Coatings formed using the higher 
modulus gels, PEGDA’s 700, 1000, and 2000, showed a significantly higher protection 
potential from lysis due to shear forces than the softer gels of PEGDA 3400 and 
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gelMA/3400 which did not significantly protect cells from lysis. This suggests that cells 
coated in the higher modulus gels (>500 kPa) experience less deformation under the same 
fluid forces and therefore reduce the number of cells lysed in the process. This same trend 
was also observed for the swelling ratio. Polymers with a swelling ratio of <5.5 showed 
significant protection when compared to uncoated cells. This data once again reinforces 
the hypothesis that the tighter crosslinked gels limit deformation reducing the number of 
cells lysed. Although the high variance in the data does not support a definitive conclusion, 
this trend may extend to ultimate tensile strength (UTS) as well. The observed UTS’s for 
the three polymers that showed significant protection (p <0.05) are not distinguishable 
between one another, but all three are significantly higher than PEGDA 3400 and 
gelMA/3400, which do not significantly protect from lysis. This again supports that the 
mechanical properties of the gel greatly influence the protective potential. 
During the simulated printing process cells experience rapid and high changes in 
pressure (~16 bar in < 0.1 s). Drastic fluctuations in pressure could potentially change the 
solubility limits of gases dissolved within the cell solution, as well as exert compressional 
forces on cells which can affect the folding properties and stability of cellular proteins [153, 
154] . Gases coming out of solution causing microbubbles have the ability to disrupt the 
cell membrane or organelles within the cell hindering or eliminating cellular function 
[155]. Changes in specific protein properties or the unfolding of proteins could reduce the 
cell’s ability maintain normal functionality. In 3D extrusion printing, the pressure change 
in the nozzle is coupled to the shear stress associated with fluid flow and cannot be 
independently varied. To de-couple these parameters and look at the effect of pressure drop 
in the absence of shear stresses, we used a pressure chamber to subject cells to the high 
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pressures experienced during extrusion without any fluid motion. The pressure chamber 
was quickly opened using a ball valve for a sudden decrease back to atmospheric pressure. 
This study revealed that pressure changes alone comparable to what cells experienced 
during extrusion in our system do not affect cell viability. Figure 7.5 shows cell viability 
for cells following high pressure conditions compared to untouched control cells. 
 
Figure 7.5: Cell viability for each assay type following exposure to high pressures (~25 
bar) and rapid decompression (< 0.1s) back to atmospheric conditions. 
There were no statistical differences in viability for any of the pressures (8-25 bar) or time 
lengths (2-10 min) studied. These pressures far exceed those reported in the literature [60, 
62]. High viability across all pressures studied supports the hypothesis that cell damage in 
extrusion printing is highly shear dependent. This study confirms that large pressure drops 
over very short time scales have no effect on cell viability when at high pressure for ~10 
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mins.  The notion of shear mediated cell damage is supported in literature for printing 
applications [65, 150, 151], but had not been independently studied. Using A DHR-2 
Viscometer (TA Instruments) cells were subject to shear forces associated with fluid 
motion without pressure driven flow. Cells coated with PEGDA 1000 as well as uncoated 
cells were exposed shear forces of ~110 Pa for 10 s, then analyzed in flow cytometry for 
viability and scattering properties. Although 110 Pa is a lower shear stress than what is 
observed through our extrusion system (~400 Pa), we are still able to induce cell lysis in 
the control population. Figure 7.6 below shows the viability of cells after exposure to shear 
forces for uncoated and PEGDA 1000 coated cells, and Table 7.3 gives p-values comparing 
viability means. 
 
Figure 7.6: Cell viability for each assay type following exposure to shear forces in the 
absence of pressure changes. (* indicates statistically different means from the 
corresponding uncoated group.) 
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Table 7.3: P-values for viability assays of coated cells compared to uncoated cells after 
being exposed to shear forces only (Figure 7.6). 
 P-Values 
Polymer Type Scattering 
Analysis 
EthD-1 MTT 
PEGDA 1000 0.039 1.52 x 10-6 1.46 x 10-4 
 
With the shear only system, as with the extrusion system, we see the PEGDA 1000 
hydrogel coating provides protection from lysis as analyzed by the scattering properties. 
The absence of a pressure changes with this system suggest the mechanical properties of 
the gel reinforce the cell membrane limiting deformation, as suggested with the extrusion 
system. These data, along with the high cell viability of cells exposed to high pressures 
further supports the notion of shear forces play the largest role in cell damage upon 
extrusion. 
The viability of all extruded cells is relatively low for what would be desired when 
bioprinting. With the exception of PEGDA 700 which we know from previous studies is 
toxic and permeabilizes cells, the viability of coated cells vs. uncoated cells in the extrusion 
system (Figure 7.3) are not statistically significant (all p-values > 0.1, Table 7.3). Figure 
7.7 shows the viability of all cells after hydrogel coating but before extrusion through the 
capillary.  
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Figure 7.7: Viability assessed by EthD-1 and MTT assay following polymerization prior 
to extrusion. (* denotes samples that showed a statistically significant drop (p < 
0.05) in cell viability following extrusion.) 
These coatings are preserving the size and shape of the cell as determined by light 
scattering in flow cytometry, but the cells lack full functionality. This may be partially due 
to monomer toxicity and may also be partially due to stressing of the cells beyond what is 
ideal for functionality without complete lysis of the cell membrane. Of all polymers 
assessed, PEGDA 2000 not only shows significant protection over uncoated cells in 
scattering analyses, but there is also no significant difference in any of the viability assays 
between before and after extrusion. P-values for Figure 7.7 are given in Table 7.4. All other 
conditions show a significant change in viability (p < 0.05). PEGDA 2000 preserves the 
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viability of cells that remain living following polymerization when extruded at high shear 
stress.  
Table 7.4: P-values generated using Student’s t-test for viability before capillary 
extrusion (Figure 7.7) to viability following extrusion of each polymer type 
and uncoated cells. 
 P-Values 
Polymer Type EthD-1 MTT 
PEGDA 700 0.011 0.322 
PEGDA 1000 3.0 x 10-6 0.0297 
PEGDA 2000 0.147 0.084 
PEGDA 3400 0.071 0.007 
GelMA/3400 0.020 0.009 
Uncoated 3.4 x 10-5 1.6 x 10-11 
 
This suggests that PEGDA 2000 may serve as the best pairing of mechanical properties of 
polymers studied with minimal cytotoxicity. A contrast to the trend in protection potential 
of each polymer is the toxicity of the chosen monomer. It is generally understood with 
PEGDA monomers of smaller molecular weights have a higher cytotoxicity prior to 
crosslinking and gelation, as observed with PEGDA 700 [131]. Although PEGDA 1000 
shows significant protection as with PEGDA 700, the molecular weight is low enough to 
cause cell damage during polymerization that, when paired with the stress of extrusion, is 
counter-productive in preserving cellular function. The molecular weights larger than 
PEGDA 2000 show an increase in viability of cells immediately following polymerization 
compared to PEGDA 2000 but also show a significant decrease in viability following 
extrusion when compared to themselves. Therefore, the production potential of the softer 
gels falls short in comparison to the stiff more crosslinked networks. 
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7.3.3 Conclusion 
 In this study we assessed polymers containing a range of different properties on a 
novel method of mechanical protection. Individually encapsulated cells were subject to 
high shear forces associated with high throughput, high resolution bioprinting. From these 
data we show that the mechanical properties of the different polymer films play a 
significant role in the protection of the coated cell. The extremely soft formulation of 
gelMA/3400 provided essentially no protection against lysis when compared to uncoated 
cells. While the higher modulus gels provide significant protection as analyzed by 
scattering analyses, they do not preserve high cell functionality. Protective cellular coatings 
of similar mechanical properties to PEGDA 700, 1000 and 2000, with higher 
cytocompatibility found in gelMA/3400 could provide mechanical protection that also 
preserves the high cellular functionality desired for organ printing
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CHAPTER 8. CONCLUSIONS AND FUTURE DIRECTIONS 
 Surface modification on living cells is an exciting field of study with a vast array 
of applications. The potential clinical benefit in areas of drug delivery, immunoprotection 
and immunocamouflage, to physical protection from chemical and mechanical insults 
makes this an intensely studied field. Modifications are accomplished through numerous 
pathways such as covalent engraftment, electrostatic interactions, hydrophobic 
interactions, and antibody/antigen binding. Here, we explore the utility of a novel 
modification strategy that utilizes specific antigen binding for immobilization of a 
photoinitiator to subsequently encapsulate target cells in a thin hydrogel film. We explore 
applications in rare cell detection/isolation for cancer screening by protection against 
chemical lysis, as well as mechanical protection for tissue and organ printing through 
membrane reinforcement. 
First, in Chapter 4 we establish a metric for cancer associated surface markers for 
potential targets in isolation. Isolation purity from a heterogeneous population using 
surface markers is largely dependent on relative expression of target markers. 
Quantification of antigen surface density relative to PBMCs gives us great insight into 
potential new targets, as well as highlights the shortcomings of current isolation strategies. 
Evaluation of the expression of commonly targeted markers on cancer cells relative to 
PBMCs indicates a lack of distinction, especially in the highly invasive cells lines. This 
indicates new and/or multiple markers will be necessary for the required selectivity of 
conventional and emerging sorting techniques. This information will greatly help current 
and future CTC isolation methods by revealing target markers that have the highest 
specificity relative to PBMCs. 
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For the greatest utility in a clinical setting, highly standardized procedures are most 
desired. Chapters 5 and 6 explore standardization of isolation through commercially 
available reagents and procedural parameters for scaling to relevant batch sizes. Previously, 
studies comparing xanthene photosensitizers have shown that eosin Y (EITC, in our study) 
greatly out performs fluorescein (FITC, in our study) in radical generation and 
polymerization ability. However, these studies were not done under the cytocompatible 
conditions required for hydrogel encapsulation. We showed that even though FITC has a 
greater spectral mismatch to our LED lamp than ETIC, significant film generation was 
achieved on both micro array slides and living cell surfaces. These findings suggest the 
plausible use of FITC which is a very common fluorophore and therefore, commercially 
sold conjugated to a range of biorecognition molecules. Commercial availability eliminates 
the need for a custom SA-EITC conjugate further standardizing our isolation system. We 
next sought to determine the key parameters associated with scaling the system to relevant 
batch sizes. Optical studies were performed on micro array slides for highly controlled 
experiments with quantitative information on film generation. Profilometry data of 
polymerizations using various conditions reveal that monomer fluid depth and incidence 
angle of radiation have large effects on film generation. This suggests that scaling 
processed volume through increased surface area and choosing a solution chamber that 
ensures minimizes presence of a meniscus is important in moving forward. 
Finally, we look to the application of physical protection from mechanical stimuli 
of our protective hydrogel. Organ printing has potential to save thousands of lives every 
year by increasing the supply of viable organs for transplant. 3D bioprinting has already 
been used to print cells and tissues for in vivo use and is rapidly approaching organ printing. 
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High shear stress accompanies commercial extrusion printers which try to attain both the 
required resolution and throughput. Here, we demonstrated that encapsulation in thin 
hydrogel coatings has the ability to reinforce the cellular membrane preventing lysis in 
high shear fluid flow. Polymers possessing a modulus similar to that of PEGDA 700, 1000, 
and 2000, while possessing the same cytocompatibility of gelMA/3400 may possess the 
ability to protect cells form lysis while preserving high functionality. Further, we 
decoupled the parameters of rapid pressure drop and high shear forces associated with flow 
and determined that shear forces of flow are primarily responsible for the hindering of 
printed cell viability. 
These studies along with previously published works in our lab demonstrate the 
versatility, feasibility, and high clinical impact that this technology possess in the field of 
cellular surface modifications for isolation, immunoprotection, and mechanical 
reinforcement. A future direction of this technology is in the degradation of the polymer 
coating. While the gelMA/3400 coating is biodegradable, efforts in a controlled 
degradation could have a high impact on clinical translation. Through the incorporation of 
photocleavable moieties, or enzymatically cleavable peptide sequences, coating removal 
could either be done so on-demand, or tune for give time scales or surrounding 
environments. As research has been done in photocleavable and enzymatically cleavable 
hydrogels, the unique polymerization process for our technology would allow for 
incorporation of such abilities with minimal change in the current system. ASL technology 
presents an exciting future with robust yet versatile applications.  
Future directions within the application of mechanical protection include the 
incorporation of branched polymer systems. As it is known that the shorter PEG chains 
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have higher cytotoxicity and we have shown that polymer modulus plays a key role in 
protection from shear forces, incorporation of branched PEG acrylates is a potential 
solution. Larger molecular weight branched PEG molecules possess similar bioinert 
properties to that of linear PEG, but with a higher functionality for polymerization. Higher 
functionality will decrease the molecular weight between crosslinks increasing the 
modulus while limiting cytotoxicity associated with low molecular weights. Incorporation 
of these branched polymers could be the key to protection from shear lysis while 
maintaining high cell functionality.  
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